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Background: Heart failure (HF) patients have high rates of hospital readmission 
resulting in large human and financial costs to families, communities, hospitals and 
payers. Developing comprehensive interventions to decrease rates requires knowledge of 
the contextual, physiological, psychological and role function factors related to 30-day 
HF unplanned rehospitalization. Objective: The aim of the study was to assess the 
influence of contextual factors (patient’s characteristics), physiological factors, 
psychological factors, and role function factors on 30-day HF unplanned 
rehospitalization. Methods: This cross-sectional study was guided by the Roy Adaptation 
Model, and Electronic Medical Record data (N = 270) were used. Chi square analyses 
and logistic regression were used to answer five research questions. Results: Findings 
revealed all factor types predicted 30-day HF unplanned rehospitalization, but in different 
levels. The contextual factors predicting 30-day HF unplanned rehospitalization were 
length of stay, previous hospitalizations, weight change between discharge and 
admission, and New York Heart Association Functional Classification (NYHA). 
Physiological factors were Chronic Kidney Disease, the use of Continuous Positive 
Airway Pressure machine (CPAP), B-type natriuretic peptide, and the use of Angiotensin 
Converting Enzymes Inhibitor medications. The psychological factor was the use of 
antidepressant, and the role function factor of being married were predictors of 30-day 
HF unplanned rehospitalization.  Conclusion: Many factors must be considered to 
prevent 30-day HF unplanned rehospitalization. Nurses should plan a variety of 
 
 
interventions that promote individuals’ health and improve health outcomes to reduce 30-
day HF unplanned rehospitalization. 
Keywords: Heart failure, 30-day HF unplanned rehospitalization, contextual 
factors, physiological factors, psychological factors, and role function factors. 
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CHAPTER I 
 
INTRODUCTION
 
 
For the past two decades, the interest in reducing the rates of Heart Failure (HF) 
unplanned rehospitalization continues to be a top priority for the government and health 
care systems. Nevertheless, the results of different studies and interventions targeted to 
this phenomenon have been contradictory. The prevalence and incidence of HF have 
been increasing, as well as 30-day HF unplanned rehospitalizations rate. In 2010, HF was 
the main cause for mortality in a sample of 58,000 patients (Go et al., 2014). Moreover, 
estimates show that approximately 800,000 patients have been diagnosed with HF every 
year (Go et al., 2014). In this study, the Principal Investigator (PI) assessed the influence 
of contextual factors (patient’s characteristics), physiological factors, psychological 
factors, and role function factors on 30-day unplanned rehospitalization in HF patients. 
The need for identifying those factors was considered an important key to develop a basis 
for tailored interventions addressing the amenable factors that would decrease 30-day HF 
unplanned rehospitalization. Also, findings provide knowledge on which to develop 
successful discharge plans that focus on specific patients’ needs and reduce the 
unnecessary expenditures associated with 30-day HF unplanned rehospitalization. 
Background and Significance 
The evaluation of the factors associated with 30-day unplanned rehospitalization 
in patients with HF has been imperative. It supports the process for designing tailored 
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interventions, to improve patient’s outcomes and improve the overall quality of care 
(Eastwood et al., 2014). Ultimately, this knowledge assists health care systems and 
providers with a focus on minimizing health care expenditures associated with HF, 
reducing hospital length of stay, providing high quality of care, relieving patients’ pain, 
safely discharging patients, and minimizing unplanned rehospitalizations.  
The significant growth in the rates of HF unplanned rehospitalizations has been a 
source of difficulties not only for patients but for families, health care providers and 
health care systems, demanding human and financial costs to achieve the best patient 
outcomes possible (Giamouzis et al., 2011; Go et al., 2014). During the past few decades, 
the number of HF patients’ visits to the emergency department (ED) significantly 
increased, despite improvement in the management of this chronic condition. A recent 
study by Hasegawa, Tsugawa, Camargo, and Brown (2014)  examined the number of 
emergency department visits for a group of HF patients in two major states (Florida and 
California). The report showed that closer to 31% of the total number of participants in 
this study scored more than 175,000 visits to the ED within the first year after discharge, 
which represented a significant number of visits. Consequently, the increase in the 
number of ED visits increased chances for HF rehospitalization in most cases. Thus, the 
findings showed that those interventions to prevent HF readmissions were not yielding 
the preferred outcome. 
Families, insurance companies, employers, the health care community and 
agencies expend a considerable amount of money to provide care for this population. 
This has resulted in an increased financial burden on the government, which 
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pays/reimburses providers and health care systems (Go et al., 2014). The costs of HF 
readmissions includes not only the cost of actual care associated with HF during these 
hospital stays, but the cost of treating any other diseases or conditions, such as, diabetes 
that may afflict the patient, too (Copeland, Berg, Johnson, & Bauer, 2010; Whellan, 
Greiner, Schulman, & Curtis, 2010). Further, the cost to families and communities may 
be decreased quality of life, lost productivity, and increased caregiving responsibilities 
and needs.  The financial burdens associated with HF include the direct cost of medical 
care as well as the expenses associated when rehospitalization occur. Areas of suggested 
study include the patient, the health care provider, and caregiver, in addition to, the 
predictors of readmission for HF patients (Coby, Marie-Louise, & Tiny, 2009).  
Generally, research in HF has included the etiology and pathophysiology, 
contributing factors, treatment modalities, HF exacerbation, and interventions that reduce 
exacerbation, and HF rehospitalization prevention. In addition, areas of  study include 
contextual factors such as patient characteristics, communication between health care 
provider and HF patients, and the level of  family and caregiver involvement in the 
process of HF care (Coby et al., 2009). 
Purpose Statement 
The aim of the study was to assess the influence of contextual factors (patient’s 
characteristics), physiological factors, psychological factors, and role function factors on 
30-day HF unplanned rehospitalization in a sample drawn from a  hospital in small urban 
area of North Carolina.  
 
 4 
HF Definition 
The Heart Failure Society of America has made significant efforts to define the 
phenomenon of HF (Lindenfeld et al., 2010), and in their report, HF was defined as:  
 
A syndrome caused by cardiac dysfunction, generally resulting from myocardial 
muscle dysfunction or loss and characterized by either left ventricular dilation or 
hypertrophy or both. Whether the dysfunction is primarily systolic, diastolic, or 
mixed, it leads to neurohormonal and circulatory abnormalities, usually resulting 
in characteristic symptoms such as fluid retention, shortness of breath, and 
fatigue, especially on exertion. In the absence of appropriate therapeutic 
intervention, HF is usually progressive at the level of both cardiac function and 
clinical symptoms. The severity of clinical symptoms may vary substantially 
during the course of the disease process and may not correlate with changes in 
underlying cardiac function. Although HF is progressive and often fatal, patients 
can be stabilized and myocardial dysfunction and remodeling may improve, either 
spontaneously or because of therapy. In physiologic terms, HF is a syndrome 
characterized by either or both pulmonary and systemic venous congestion and/or 
inadequate peripheral oxygen delivery, at rest or during stress, caused by cardiac 
dysfunction (p. 480). 
 
 
HF is a syndrome where the heart is unable to maintain cardiac output, which 
leads to a lack of oxygen supply to organs, resulting in a failure to meet the metabolic 
demands for these organs. The symptoms associated with HF depend on which organ has 
a lower blood supply, and the extent of the resulting lack of oxygenation. The majority of 
HF patients exhibit symptoms of fluid retention which is called congestive heart failure 
(CHF) (Copstead & Banasik, 2005). Currently, HF has no cure, so the available treatment 
modalities aim to alleviate the symptoms associated with heart failure, prevent 
deterioration, and improve quality of life. 
 
5 
HF is classified based on the severity of the symptoms; the most widely used 
classification is the New York Heart Association (NYHA) Functional Classification. HF 
is classified into four major categories: 
1) Class I:  No limitation of physical activity. Ordinary physical activity does not 
cause undue fatigue, palpitation, dyspnea (shortness of breath). 
2) Class II: Slight limitation of physical activity. Comfortable at rest. Ordinary 
physical activity results in fatigue, palpitation, dyspnea (shortness of breath). 
3) Class III: Marked limitation of physical activity. Comfortable at rest. Less 
than ordinary activity causes fatigue, palpitation, or dyspnea. 
4) Class IV: Unable to carry on any physical activity without discomfort. 
Symptoms of heart failure at rest. If any physical activity is undertaken, 
discomfort increases. 
HF is best explained as being the final point following specific cardiac disorders, 
such as, high blood pressure, coronary artery disease, valve disease, repeated myocardial 
infarction; or chronic non-cardiac disorders such as, diabetes (Go et al., 2014). It greatly 
affects the person’s ability to care for themselves, often referred to as HF self-care (D. K. 
Moser et al., 2012). Heart failure is linked to higher rates of mortality and morbidity, and 
those rates are significantly influenced by the exacerbation of HF symptoms, such as 
increases in shortness of breath experienced with physical exertion (Barsheshet et al., 
2010). HF contributes to and compounds other illnesses that often result in a significant 
increase in health care spending, and unplanned rehospitalizations (Esposito, Bagchi, 
Verdier, Bencio, & Kim, 2009). Therefore, the early detection and treatment of HF is 
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crucial to lower both morbidity and mortality rates, as well as, HF care expenditures 
(Manzano, Escobar, Cleland, & Flather, 2012). 
HF is a major condition that can occur at any stage of an individual’s life, though 
older adults (>65 years) are at higher risk for having cardiac related disorders, such as, 
HF because of the physiological and functional changes with aging. The literature 
suggests that individuals 65 years and older represent more than two thirds of the total 
population with HF in the United States (Chiung-Zuan & Jun-Jack, 2007). Specifically, 
the prevalence of HF is found to be higher after the age of eighty (Carmen Van Voorhis 
& Morgan., 2007). 
Etiology of HF 
Different disorders or conditions can lead to HF. These disorders are classified 
under two major categories: Ischemic cardiomyopathies and non-ischemic 
cardiomyopathies. The most frequent condition is the ischemic cardiomyopathies such as 
myocardial infarction and hypertension. The non-ischemic cardiomyopathies, which  
include dilated cardiomyopathy, inherited heart disorders, respiratory disorder, anemia 
and hyperthyroidism conditions, were found to be less common (Copstead & Banasik, 
2005). 
Most often HF results because of: 1) the inability of heart fibers to contract, which 
is referred to as systolic HF, or 2) the inability of heart fibers to relax, which is called 
diastolic HF, or 3) the combination of both (Copstead & Banasik, 2005). The taxonomy 
of HF into systolic and diastolic is built on the value of the left ventricular ejection 
fraction (EF). Normally, the value of EF is between 60-80%. The systolic HF is 
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characterized by an ejection fraction below 40%, whereas diastolic HF is characterized 
by normal (>40%) or close to normal EF. Overall, HF results due to significant damage 
to the heart muscles, and such damage is considered irreversible. The damage to the heart 
muscles, and the associated dysfunction, occur because of preceding cardiac diseases, 
such as, hypertension and myocardial infarction. 
Condition Indicators 
In most cases, HF symptoms are not specific, which has made the diagnosis of HF 
challenging. The major symptoms of HF exacerbation are dyspnea, fatigue, edema 
(localized or generalized), and a lower level of motor activities. The major signs of HF 
include muscle wasting, tachycardia, wheezing, irregular heart sounds, elevated jugular 
venous pressure, ascites and enlarged liver (Watson, Gibbs, & Lip, 2000). 
Dyspnea is one of the common symptoms associated with heart failure. This 
symptom results from fluid overload in both lungs to the extent that lungs are unable to 
expand, and is moderately used to assess the incidence of HF. Dyspnea is  not definitive 
or specific only to HF and may be due to some types of respiratory disorder. Fatigue is 
considered a symptom of HF, which usually results because of the lack of oxygen supply 
and lack of blood flow to different muscles, mainly the skeletal muscles. This lack of 
oxygenation will lead to major alteration in the structure and elasticity of the muscles, 
consequently causing severe damage to the muscles and, thus, fatigue. Edema is one of 
the most common HF symptoms, and one that is easy for the patient to recognize. 
Usually edema is located around the ankles and feet, but can be in other parts of the body, 
such as the abdomen. Typically, edema occurs because of right-sided HF. This type of 
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failure causes pain to the right side of the abdomen due to liver enlargement and 
abdominal distension. The weight increase in HF patients is mainly associated with 
edema; therefore monitoring body weight is considered as a valid indicator to determine 
the effectiveness of HF treatment (Watson et al., 2000). 
The signs of HF exacerbation include tachycardia, jugular vein distention, and 
irregular heart sound, mainly S3 (the displaced apex beat). Tachycardia (acceleration in 
heart rate) is one of the signs for HF exacerbation, although not specific. Tachycardia is a 
premature sign that the heart is working harder to meet the metabolic demands of other 
organs. One of the major signs of HF in patients with history of cardiovascular disease is 
jugular venous distention; this sign is considered a strong indicator for the presence of HF 
that can be recognized easily during a physical examination. Unless HF was not caused 
by a preceding cardiovascular disorder, then this sign becomes less valid (Watson et al., 
2000). Finally, the presence of abnormal sounds with heart auscultation, mainly S3, is 
believed to be associated with HF. Often recognition of this sign is limited to experiences 
professionals, and thus is not a common finding in primary care. 
Prevalence and Incidence 
 
Over the past three decades, a major development has been noticed in the area of 
HF diagnosis and treatment, with a significant increase in the use of evidence-based 
practices. This revolution resulted in serious improvements in health outcomes, as 
evidenced by significant decreases in mortality and improved quality of life. However, 
the prevalence of HF in the United States and across the globe is significantly continuing 
to trend upward. In 2010, HF was considered the primary cause for mortality in a sample 
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of 58,000 elderly patients (Go et al., 2014). Moreover, it has been estimated that more 
than 800,000 patients are being diagnosed with HF every year.  Data from the National 
Health and Nutrition Examination Survey (NHANES) (2007-2010) showed that more 
than five million patients age 20 years and older have been diagnosed with HF (Go et al., 
2014). It has been anticipated that there will be an increase in the numbers of patients 
with HF,  up to 46% for the period of 2012 to 2030, which represent a new 8 million HF 
patients who are 18 years and older (Heidenreich et al., 2013) for which to provide care 
and support. 
Reports from the Framingham Heart Study have showed that HF incidence 
reaches a level of 10 per 1000 after the age of 65 years. The report stated that after the 
age of 40, the lifetime risk for developing HF in males and females was around 20 
percent, though the life time risk for individuals who have blood pressures higher than 
160/100 mm Hg was double that of  an individual with blood pressures less than 140/90 
mm Hg  (Lloyd-Jones et al., 2002). The Multi-Ethnic Study of Atherosclerosis results 
showed that African Americans had the highest level for developing HF (4.6 per 1000), 
followed by Hispanic (3.5 per 1000), white (2.4 per 1000), and Chinese Americans (1.0 
per 1000). Moreover, the higher risk for HF in African Americans was caused by the 
higher prevalence of hypertension and diabetes in that group (Bahrami et al., 2008). 
The analysis of data from four different United States communities for the period 
between 1987 to 2002 showed that the age adjusted incidences of HF in white women 
was 3.4 per 1000, which is considerably lower than the rates of white men (6.0 per 1000), 
black women (8.1 per 1000), and black men (9.1 per 1000). Again, the higher rates of HF 
 
10 
in African Americans were linked to the higher number of cardiovascular risk factors 
associated with HF in that population, such as, hypertension (Loehr, Rosamond, Chang, 
Folsom, & Chambless, 2008). 
As previously mentioned, the cost of hospital admissions related to HF has 
increased significantly over the past few decades. The increase in costs has been 
compounded due to the presence of multiple comorbidities, including, hypertension, 
atrial fibrillation, and coronary artery disease (Esposito et al., 2009). The patient often 
has one or more of those afflictions in addition to HF, which can lead to an increased 
number of visits to hospitals’ emergency departments. A higher level of ED visits can 
increase their chances of being admitted to the hospital (Esposito et al., 2009). In 2009, it 
was estimated that one million patients with HF were admitted to hospitals across the 
United States; with a total cost of 34 billion dollars for these admissions (Britz and Dunn, 
2010). In 2012, the cost was reduced to 30.7 billion, but still considered high when taking 
into consideration all the costs associated with providing different interventions (Go et 
al., 2014). In 2012, the costs for HF care represented more than 65% of the total health 
care costs for the entire year, and it is expected that the direct medical cost of HF care 
and associated treatment will double by 2030 ( $70 billion), or roughly about $250 for 
every resident of the United States (Heidenreich Pa et al., 2013). 
HF Unplanned Rehospitalization 
HF has been found as the most common cause for rehospitalizations in adults that 
influences all areas of life, such as physical, physiological, and psychological aspects of 
life (Go et al., 2014; Vasiliki et al., 2010). HF readmission refers to the patient’s 
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admission to a hospital within a certain number of days (7, 30, 90,180, and 360) after 
discharge with the same diagnosis (HF). The rates of HF unplanned rehospitalizations 
continue to increase, with little modification and reduction to those rates (Ross et al., 
2010). In general, the literature suggests that the rates of HF readmission are trending 
upward at 7-day, 30-day, 60-90 day and 180-day, with an increase by 5.6%,16%-25%, 
30% and 45% respectively (Eastwood et al., 2014; Gregg C. Fonarow et al., 2007; 
Jencks, Williams, & Coleman, 2009; Keenan et al., 2008; H. M. Krumholz et al., 1997; 
Ross et al., 2010). In some studies, rehospitalizations included more than half of the total 
patients discharged with HF (Joynt & Jha, 2011; Harlan M. Krumholz et al., 2009; 
Setoguchi & Stevenson, 2009). Similarly, older adults with HF have higher risks for 
readmissions with minimal reduction regardless of the different interventions that have 
targeted this population (Ross et al., 2010). The latest statistics for older adults aged 65 
and older and have Medicare as their primary insurance has revealed that the average 
number of HF readmissions had not changed in the past few years, indicating a lack of 
reduction in these readmission rates (Ross et al., 2010). Therefore, the focus on this 
phenomenon became a top priority to the government, health care providers, payers, 
families and communities. 
As the rates of unplanned rehospitalizations in HF patients increase, the cost of 
the associated treatment increases significantly. In response to these increases, the Center 
for Medicare and Medicaid Services (CMS) has decided to stop reimbursement for 
avoidable readmission occurring within thirty days after discharge (Centers for Medicare 
& Medicaid Services, 2014). Also, CMS has a plan to penalize hospitals with higher rates 
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of readmissions and provide incentives for the hospitals with lower rates of readmissions. 
The new policies and guidelines by CMS provide new challenges for health care systems 
and providers, forcing them to find strategies to reduce or eliminate HF 30-day unplanned 
rehospitalizations (Centers for Medicare & Medicaid Services, 2014).  
Factors that Influence HF Unplanned Rehospitalization 
Multiple factors influence HF unplanned rehospitalizations. Commonly, a fair 
number of rehospitalizations related to HF can be prevented by early detection of the 
signs and symptoms of exacerbation events, recognizing the predisposing factors, and 
engagement in self-management behaviors (D. Moser & Mann, 2002). The contributing 
factors for HF readmission include but are not limited to: 1) Patients’ non-compliance 
with prescribed medications, cardiac healthy diet, and fluid restrictions; 2) Patients’ non-
compliance to the treatments prescribed by health care providers for different cardiac and 
non-cardiac risk factors, such as, hypertension and diabetes; 3) Poor management for 
cardiac arrhythmias associated with HF; 4) Higher doses of selected medications, such as, 
negative inotropic agents; 5) Pulmonary embolism; 6) Higher doses of nonsteroidal anti-
inflammatory drug (NSAID), and 7) Endocrine irregularity and different types of 
infections (Hunt et al., 2009). In addition, there have been distinct factors that influence 
HF readmission within 30-days after hospital discharge, such as, episodes of edema (fluid 
retention), higher creatinine level and lower systolic blood pressure (Muzzarelli et al., 
2010).  Heart failure rehospitalization within 90 days significantly increased in patients 
with a co-diagnosis of coronary artery disease (CAD). Similarly, the risk for HF 
rehospitalization increased significantly with the presence of an implanted 
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pacemaker/defibrillator device, high jugular venous pressure, aging, and depressive 
symptoms (Muzzarelli et al., 2010). Moreover, diabetes mellitus and the number of 
previous hospitalizations were found to raise the chance for HF rehospitalization (Corrao, 
Ghirardi, Ibrahim, Merlino, & Maggioni, 2015; Vasiliki et al., 2010). Finally, depression 
and the associated symptoms have been related to increased HF rehospitalization rates in 
adults (Song, Lennie, & Moser, 2009). 
Conceptual Framework 
The conceptual framework for this study is based on the Roy Adaption Model 
(RAM). The root of the adaption model started in 1964, when Sister Callista Roy as a 
graduate student started to develop a model to guide nursing practices (Masters, 2012). 
The first version of her model was published in 1970 as an article called “Adaptation: a 
conceptual framework for nursing.” In 1991, the final and refined version of Roy’s model 
was completed. Now, the RAM has been adopted broadly to guide nursing research and 
practice all over the world. The model is used in other health care fields (Andrews & 
Roy, 1991). 
Roy’s model has inspired authors to write books about the concept of adaptation 
in nursing science (Lutjens, 1991; Rambo, 1984; Randell, Tedrow, & Van Landingham, 
1982; Seo-Cho, 1999). It helped in the process of expanding nursing knowledge by 
guiding research in health care setting and nursing education. The RAM was applied to 
multiple populations with different characteristics and backgrounds (Masters, 2012). The 
model has been widely used in health care, mainly for examining health status and the 
adaption in stressful situations such as cancer (P. Henderson, 2003; Poirier, 2007; 
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Ramini, Brown, & Buckner, 2008; Samarel, Tulman, & Fawcett, 2002; Tulman, Fawcett, 
& McEvoy, 1991; Zeigler, Smith, & Fawcett, 2004), chronic obstructive pulmonary 
disease and HF (Akyil & Ergüney, 2013; Bakan & Akyol, 2008; Tsai, Tak, Moore, & 
Palencia, 2003; Whittemore & Roy, 2002), end of life issues (Dobratz, 2011), pregnancy 
and postpartum issues (Isbir & Mete, 2010; Pollock, Amankwaa, & Amankwaa, 2005; 
Posmontier, 2008) , AIDS (Perrett & Biley, 2013; Phillips, 2011; Waweru, Reynolds, & 
Buckner, 2008), and caregiver issues (Levesque, Ricard, Ducharme, Duquette, & Bonin, 
1998). 
The model considers an individual as a bio-psycho-social-spiritual element, and 
emphasized on the importance of the balance between those elements. The RAM looks at 
the individual holistically, and addresses several aspect of human being study.  
The RAM emphasizes the importance of providing nursing care for different 
populations from different cultures. The individual is considered an adaptive structure 
that continuously adjusts to different environmental stimuli both internal and external 
(Masters, 2012). Usually, the surrounding environment is the main foundation for 
different stimuli, which may improve or jeopardize the total human structure, thus 
increasing their adaptation or leading to maladaptation. Roy classified the stimuli into 
three major categories:  Focal stimuli are classified into internal and external variables 
that directly influence the adaption of human structure, and draw the individual’s 
attention to adapt. Contextual stimuli are defined as further stimuli that boost the 
influence of focal stimuli. Residual stimuli are defined as all other phenomena that rise 
from the individual’s surrounding either internally or externally and influence the focal 
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stimuli. The adaptation level is defined as the different types of stimuli influencing the 
individual’s structure and triggering their adaptation mechanism to maintain a healthy 
level of adaption (Andrews & Roy, 1991).  
Adaptation as defined by Roy is “the process and outcome whereby thinking and 
feeling persons as individuals or groups or in groups, use conscious awareness and 
choices to create human and environmental integrity” (Roy & Andrews, 1999, p. 54).  
Roy proposed two coping mechanisms that occur as consequence to different stimuli. The 
first mechanism is called regulator, which include the response to stimuli through, 
nervous, endocrine, and chemical mechanisms. The stimuli send signals through different 
channels that will activate certain mechanisms and lead to change in electrolytes and 
fluid status in the human body. The second mechanism is called cognator that include the 
response to stimuli through cognitive and emotional process (Andrews & Roy, 1991). To 
measure coping mechanism, Roy proposed that these mechanisms including both 
regulator and cognator could be measured through behaviors of human beings exhibited 
after any exposure to different types of stimuli. Roy further explained that the human as 
an adaptive structure displays different types of behaviors in response to stimuli; Roy 
called them “adaptive modes.” These modes include physiologic-physical, self-concept-
group identity, role function, and interdependence mode. Roy indicated that adaptation 
occur as a result to the interaction between those modes and different environmental 
stimuli (Roy & Andrews, 1999). 
Roy’s adaption model has a variety of assumptions; those assumptions are 
categorized under three major areas: philosophical, scientific, and cultural. The 
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philosophical category included: a) the association between an individual and 
environment, in addition, the association with god; b) human significance is imbedded in 
an omega point merging the universe; c) god is discovered in the multiplicity of creation 
and is the endpoint for all creation; and d) humans are accountable for the process of 
arising, supporting, and converting the world (Roy, 2008).  The scientific assumptions 
include: a) systems of matter and energy advance with time to more complicated level of 
self-organization, b) consciousness and meaning result because of the assimilation 
between human and the environment, c) self-awareness and environmental awareness 
ingrained feeling and thinking, d) thinking and feeling reconciles human activities, e)  
human and globe have common pattern and  f) the interaction of human and atmosphere 
create adaptation (Roy, 2008). The cultural assumptions include: the RAM is sensitive to 
how each person perceived the element of RAM in their culture, the main concept in the 
RAM is the one that is most important to the culture. the cultural influence might 
influence nursing practice mainly for practices that adopt RAM, and based on the 
practiced culture in an area, the use of the RAM in research might vary taking into 
account the culture (Roy, 2008). 
The RAM has three components that were used in this study: Input/stimuli 
(internal and external); Effectors/ adaptive mode (promote or threaten the adaption level); 
and Output/adaptive response (see Figure 1). Different studies have utilized the RAM to 
show that human beings are considered coping units. In general, beings adapt to the 
presence of environmental stimuli (input). Then effectors (adaptive mode) are used to 
adjust to a stimuli and provide, when individual lack adaption to certain stimuli, a loop 
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and feedback as a stimuli in that model. The model was used to assess the influence of 
contextual factors of patient’s characteristics, physiological factors, psychological 
factors, and role function factors (socioeconomic status) on 30-day HF unplanned 
rehospitalization. In the conceptual model for this study, it was hypothesize that there 
was an association between different stimuli, for example, the patient’s characteristics, 
physiological factors, psychological factors, and role function and the adaptive response 
(effective or ineffective) in HF patients see Figure (1). By examining the relationship 
between stimuli and 30-day HF unplanned rehospitalizations, a better understanding of 
the HF patients at higher risk for rehospitalization in this population was developed. 
Figure (1) The Roy Adaptation Model. 
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Figure 1.  Roy Adaptation Model 
 
 
For the purpose of this study, HF patient was considered an adaptive system. The 
patient with HF encounters a variety of stressors during the life span. However, over the 
period of HF hospitalization, patients were exposed to numerous stressors, including, 
length of stay, pharmacological treatment, the presence of comorbidities, and changes in 
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lab results that influenced the level of patient’s adaption (spend more or less time at the 
hospital). The degree of adaptation, unplanned rehospitalization, was measured by the 
level of adjustment and maladjustment to these stressors. 
As Roy suggested, nurses are encouraged to expand the adaptation zone for 
patients with chronic conditions such as HF. In addition, nurses need to help patient adapt 
to stressors. In general, HF patients show a significant maladaptation to stimuli that might 
occur before, during and after hospitalization, and because HF is a condition that requires 
major consumption of health care services, successful adaption is preferred to increase 
the effectiveness of adaptive response, consequently decrease the rates of 30-day HF 
unplanned rehospitalization, and improve quality of life. 
The concepts under RAM were identified as the following: HF as a chronic 
condition was considered the focal stimulus, which threatened the adaptation of human 
structures during hospitalizations and after discharge. The contextual stimuli were the 
patient characteristics, such as age, gender, and race, which should have boosted the 
influence of HF on patient’s level of adaptation during hospitalizations, and decreased 
their risk for 30-day unplanned rehospitalization after discharge. Finally, the residual 
stimuli were defined as all other unknown variables excluding focal and contextual that 
might have influence on the adaption level of HF patients during hospitalizations and 
might influence 30-day unplanned rehospitalization after discharge. 
The RAM proposed four different adaptation modes and three were used in this 
study. The physiological-physical mode included the physiological activity of cells, 
tissue, organs, and the system inside human being. This mode focused on the stability of 
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the acid-base, endocrine, and neurological functions inside the individual (Roy, 2008). 
The physiological-physical mode in this study was operationalized as the general health 
status of the HF patient during hospitalization and was measured by the stability of the 
physiological status including, the presence of cardiovascular or non-cardiovascular 
conditions, the laboratory values (normal of abnormal), and the use of cardiac related 
medications. The second mode was the self-concept mode. This mode included the 
psychological aspect of human being, self-image, self-consistency, and spiritual belief 
system (Roy, 2008). In the proposed study, this mode was operationalized by general 
psychological conditions that could have influenced self-image and the patient’s 
psychological status during hospitalization, such as, depression and anxiety. The third 
mode of adaptation was the role function mode, operationalized as the role of a person in 
the society and how individuals’ roles influenced their level of adaption (Roy, 2008). In 
this study, the roles were measured by patient’s living situation, marital status, insurance, 
and employment status of the HF patients. Finally, unplanned rehospitalization within 30-
day was considered maladaptation of HF patient after discharge.  Thus, maladaptation to 
stimuli from different origins in HF patients increased the chances for unplanned 
rehospitalization. By focusing on the balance between different types of stimuli, HF as 
chronic condition, and the environment, the RAM was very useful to guide this study 
examining of 30-day unplanned rehospitalization in HF patients. 
Research Questions 
Are contextual stimuli (patient’s characteristics, such as, age, gender, race, length 
of stay, residency area, BMI (body mass index), number of previous hospitalizations, 
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difference in weight between discharge and admission, and the New York Heart 
Association Functional Classification) associated with 30-day unplanned 
rehospitalization in adults with heart failure? 
What physiological factors are associated with 30-day unplanned rehospitalization 
after adjusting for age in adults with heart failure? 
a) Which cardiovascular and non-cardiovascular conditions is associated with 
30-day unplanned rehospitalization after adjusting for age in adults with heart 
failure? 
b) Which laboratory values (normal or abnormal) are  associated with 30-day 
unplanned rehospitalization after adjusting for age in adults with heart failure? 
c) Which type of cardiac related medication is associated with 30-day unplanned 
rehospitalization in adults with HF patients? 
Are psychological factors, such as, the diagnosis of depression and anxiety 
associated with 30-day unplanned rehospitalization after adjusting for age in adults with 
heart failure? 
Are role function factors, such as the patient’s living situation, marital status, 
insurance, and employment status associated with 30-day unplanned rehospitalization in 
adults with heart failure? 
Are the combined contextual factors of patients’ characteristics, physiological 
factors, psychological factors, and role function mode associated with 30-day unplanned 
rehospitalization in adults with heart failure? 
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Definition of Terms 
Heart Failure (Theoretical): is “the end stage of a cardiac disease, it is most often 
a consequence of hypertension, coronary heart disease, valve deformity, diabetes, or 
cardiomyopathy” (Rosamond et al., 2008, p. e87). 
Heart Failure (Operational): a patient with HF will be defined a patient who is 21 
years and older with a medical diagnosis of heart failure. 
Hospitalization (Theoretical): as defined in the dictionary is “the act or an 
instance of being hospitalized”("hospitalization ", 2014). 
Hospitalization (operational): The length of admission HF patients spends in the 
hospital under inpatient status. 
Unplanned Rehospitalization (Theoretical): It is defined as the readmission to the 
hospital with a primary diagnosis of HF within 30-days after being discharged. 
Discharge period (Operational): is defined as the time from being released from 
the hospital (the point when HF patient has left the hospital) and up to 30 consecutive 
days after the release. 
Physiological factors (Theoretical): as defined in the dictionary as “characteristic 
of or appropriate to an organism's healthy or normal functioning.”("Physiological," 
2014). Or it is defined as: The functions and properties of living organisms, including 
both the physical and chemical factors and processes, supporting life in single- or multi-
cell organisms from their origin through the progression of life (Pubmed, 2014a). 
Physiological factors (Operational): For the purpose of this study, physiological 
factors were defined as the cardiovascular and non-cardiovascular condition related to 
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heart failure, laboratory values (normal or abnormal) during hospital stay, and the type of 
cardiac related medication that HF patients are taking.   
Psychological factors (Theoretical): “Mechanisms and underlying psychological 
principles of mental processes and their applications.”(Pubmed, 2014b) 
Psychological factors (operational): For the purpose of this study, psychological 
factors was defined as the presence of mental conditions that might influence 30-day 
unplanned rehospitalization in HF patients. 
Role function (Theoretical): “the role function focuses on the roles of the person 
in society and within a group.” (Roy, 2008, p. 49)  
Role function (operational): For the purpose of this study role, function was 
defined as by the current living status of HF patient, the marital status (married/not 
married), employment status (employed/unemployed), and the insurance status 
(insured/uninsured).                          
Summary 
Heart failure is a chronic condition with high incidence, prevalence, and 30-day 
unplanned rehospitalizations. The interest in reducing the rates of HF 30-day unplanned 
rehospitalization continues to be a top priority for the government, health care systems, 
payers, families and communities.  However, results of previous studies and interventions 
targeting this phenomenon have not been consistent in producing the outcomes desired. 
Identifying different factors that influence 30-day unplanned rehospitalization in HF was 
the focus of this study to provide a basis for developing tailored interventions and a 
successful discharge plan that focuses on specific patients’ needs. The Roy Adaptation 
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Model was used to guide the study.  Focal, contextual and residual stimuli were included 
and three modes of adaptation were used. In this study, the PI assessed the relation of 
contextual factors (patient characteristics), physiological factors, psychological factors, 
and role function factors on 30-day unplanned rehospitalization in HF patients. This 
study was developed because of the increased interest in reducing 30-day unplanned 
rehospitalizations among HF patients in compliance with the current CMS guidelines. 
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CHAPTER II
LITERATURE REVIEW 
 
Unplanned rehospitalization refers to patients’ admission to a hospital because of 
the same diagnosis within certain amount of days (usually between 7-30 days). It is 
different from planned rehospitalization, which usually arranged by a health care 
provider, for example, a patient admitted for a cardiac catheterization. Based on the result 
of the procedure; the physician would ask the patient to come back for further evaluation, 
or an intervention, such as pacemaker placement. Previous scientific literature has 
identified different factors linked to increased chance for HF rehospitalization. 
Identifying HF patients at higher risk for rehospitalization is crucial and beneficial in the 
process of developing screening tools, and HF specific interventions. Mihai Gheorghiade, 
Vaduganathan, Fonarow, and Bonow (2013)  suggested that in order for health care 
systems to develop efficient approaches in addressing and decreasing the chances for HF 
unplanned rehospitalization, they need to : 1) follow what is called “mechanistic 
approach” to identify the most likely conditions that increase the chances for HF 
rehospitalizations, and develop tailored interventions to treat these conditions. 2) 
Implement treatment modalities in clinical practice, in addition to, a variety of disease 
management programs that were developed based on evidence-based practice and 
compatible with the current treatment guidelines. 3) Focus on assessing and managing the 
non-cardiac morbidities, such as diabetes. Moreover, assess the need for patient’s 
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transition to home with home health services or to a skilled facility, emphasize on follow 
up, and continue to monitor patients after discharge. 
The factors that influence HF unplanned rehospitalization include patient’s 
characteristics, physiological factors, psychological factors, and socioeconomic status. 
The literature suggests different classification to those predictors. However, for the 
purpose of the study these factors were selected because of their main role influencing 
HF 30-day unplanned rehospitalization. 
Patient Characteristics 
These factors were identified as booster to the influence of HF as a disease and a 
condition that puts pressure on patient’s capability to adapt (live healthy life as much as 
possible), or encounter maladaptation (rehospitalization within 30-day). These factors 
included, age, gender, race, length of stay, residency area, BMI, number of previous 
hospitalizations, difference in weight between discharge and admission, and the New 
York Heart Association Functional Classification. 
The rates for unplanned rehospitalization heighten significantly with age. The age 
of an individual with HF was found to be significant predictor for 30-days HF 
readmission (Corrao et al., 2015; Ogah et al., 2014; Prasun, Verhulst, Weller-Summers, 
Baur, & Nallamothu, 2013). Kossovsky et al. (2000) noted that the odds ratio for 
readmission risk increased to 3.3 and 4.1 for the HF patients in the study aged 65-79 year 
and >80, respectively. In addition, the HF readmission rates were anticipated to increase 
by 24% every decade of life (Toshimi Koitabashi et al., 2005). Moreover, aging was 
 
27 
found to be an antecedent for HF readmission in both Asian and African American 
population (R. Lee et al., 2009; Shinagawa et al., 2008).  
Patient’s gender has been identified as a determinant for HF rehospitalization. 
Male gender was linked to higher percentages of HF rehospitalization in several studies 
(Alla et al., 2007; Blackledge, Newton, & Squire, 2003; Toshimi Koitabashi et al., 2005; 
H. M. Krumholz et al., 1997). Numerous studies have shown that female gender is 
associated with higher percentages of HF readmission (Frazier et al., 2007; Howie-
Esquivel & Dracup, 2007; Ingrassia, Soucier, Woiciechowski, Cyr, & Crowell, 2015; 
Mielniczuk et al., 2008; Opasich et al., 2004). While the result of different reports about 
the influence of gender on HF readmission were contradictory, there are studies that have 
revealed that gender was not linked to either an increase or a decrease in the chances for 
HF rehospitalization (W. Y. Lee, Capra, Jensvold, Gurwitz, & Go, 2004; Sheppard, 
Behlouli, Richard, & Pilote, 2005; Vaccarino, Chen, Wang, Radford, & Krumholz, 
1999). 
Race was considered to influence HF rehospitalizations. The analysis of several 
studies that examined the effect of race on rehospitalization rates among individuals with 
chronic conditions, such as, HF found that an individual’s race is an important factor that 
contributes to increased risk for readmissions (Curtis et al., 2008; Fátima, Karen, Lenny, 
Fidencio, & Ashish, 2011; Friedman & Basu, 2004). Yet, other studies revealed no 
association between race and HF readmission (Agoston et al., 2004; Blackledge et al., 
2003; Gambassi et al., 2008). Two studies by R. Lee et al. (2009) and Howie-Esquivel 
and Dracup (2007) illustrated that certain racial groups, such as, African Americans have 
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a higher likelihood to be rehospitalized compared to whites. Both groups of African 
Americans and Hispanics were at greater risk to be rehospitalized than Whites and Asians 
(Afzal et al., 1999; E. F. Philbin & DiSalvo, 1998; Rathore et al., 2003).  
Although African Americans who have Medicare receive comparable quality of 
care to other ethnic and racial groups, African Americans had slightly higher rates of HF 
readmission, and poorer 1-year mortality level compared to whites (Wheeler et al., 2004). 
Also, African Americans were found to utilize hospitals for HF management more often 
than whites (Lafata, Pladevall, Divine, Ayoub, & Philbin, 2004). African Americans have 
the lowest decreases in HF hospitalization rate for the period of 1998-2008 (Chen, 
Normand, Wang, & Krumholz, 2011). Hispanics patients with HF were found to have 
different representations than any other racial group. They have unique needs that require 
different strategies to address these needs, including designing special HF management 
programs for Hispanics that are sensitive to their cultural background (Vivo, Krim, 
Cevik, & Witteles, 2009). 
The length of hospital stay for HF patients was correlated with readmission. The 
research by H. M. Krumholz et al. (1997) implied that the chances for HF readmission 
(within 180 days) increase significantly for patients hospitalized for more than a week. 
For patients hospitalized more than 2 weeks, the risk for rehospitalization rose 3.2 fold in 
the first year after discharge (Tsuchihashi et al., 2001).  
In general, patients who lived in a lower income area, such as rural areas, had a 
higher risk for rehospitalization (F. Philbin, Dec, Jenkins, & DiSalvo, 2001). The change 
in weight during hospitalization was found to increase the chances for readmission in HF 
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patients (Thavendiranathan et al., 2013). In addition, body mass index was found to be a 
significant predictor for 30-day HF readmission, the increase in BMI was found to be 
significant in elevating the chance for HF readmission (Prasun et al., 2013). However, 
Ogah et al. (2014) found that the decline in BMI is linked to higher rate of HF 
readmission. Finally, a history of prior hospitalization was linked to more repeated 
rehospitalization as implied in several studies (Darze et al., 2007; Felker et al., 2003; 
Gackowski et al., 2004; Kossovsky et al., 2000; H. M. Krumholz et al., 1997). 
Other cardiovascular factors anticipated to influence HF unplanned 
rehospitalizations include heart rate, and HF class based on the New York Heart 
Association (NYHA) Functional Classification. The elevated heart rate for HF patients 
during hospitalization was linked to increased markers for 30 and 60-day readmissions 
(Bettencourt et al., 2004; Sliwa et al., 2013; Triposkiadis et al., 2009). Moreover, the 
NYHA class was found to be associated with HF rehospitalization. The literature shows 
that the more advanced in NYHA class at discharge the more risk for higher 30-day and 
one year HF rehospitalization (Feola et al., 2008; Toshimi Koitabashi et al., 2005; R. Lee 
et al., 2009).  
Physiological Factors 
The physiological factors known to have influence on HF, and consequently 
rehospitalization were divided into cardiovascular factors such as, high blood pressure, 
coronary artery disease, peripheral artery disease, arrhythmia, and heart valve problems, 
and non-cardiovascular factors such as, endocrine, renal, respiratory, metabolic, 
neurological, musculoskeletal, nutritional, and hematopoietic (Metra et al., 2011). Also, 
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HF rehospitalizations were influenced by certain abnormal laboratory values, and certain 
cardiac medications. Over the past decades, these are the main physiological factors that 
show influence on the incidence of HF, and are important to control, if we are looking to 
better manage HF, and reduce the associated unplanned rehospitalizations. 
Cardiovascular Factors 
Generally, the influences of the different physiological factors on HF 
rehospitalization have been examined thoroughly in the nursing and medical literature. 
The combination between HF and ischemic related conditions such as, myocardial 
infarction, coronary artery bypass graft, and percutaneous transluminal coronary 
angioplasty correlates significantly with patients’ rehospitalization (Evangelista, Doering, 
& Dracup, 2000; Felker et al., 2003; Kossovsky et al., 2000; R. Lee et al., 2009). Ejection 
fraction (measurement of how healthy the heart is pumping) is found to be a determinant 
for HF readmission (G. C. Fonarow et al., 2007; MacDonald et al., 2008; Sliwa et al., 
2013), mainly low ejection fraction is linked to a higher rates of HF rehospitalization 
(Babayan et al., 2003; Pernenkil et al., 1997).  
One of the main cardiovascular conditions that influence HF rehospitalization 
rates was hypertension (Tsuchihashi et al., 2001). The prevalence of hypertension in HF 
patients is increasing, Braunstein et al. (2003) reported that the prevalence of high blood 
pressure in a group of 122,630 older adults with HF was more than fifty percent. As 
hypertension is a common phenomenon found in HF patients, the need to address it 
became an underpinning in the process of identifying HF patients at higher risk for 
unplanned rehospitalization. Low blood pressure was found to be a determinant for HF 
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rehospitalization as well (Brophy, Dagenais, McSherry, Williford, & Yusuf, 2004; Felker 
et al., 2003; Levy et al., 2006). The odds of HF readmission were elevated when systolic 
blood pressure was increased at discharge in contrast to admission (Wettersten, Wilson, 
Tong, & López, 2014).  Moreover, the risk for readmission in two months was 
anticipated by the value of systolic blood pressure on admission (Sliwa et al., 2013). The 
study conducted by Vinson, Rich, Sperry, Shah, and McNamara (1990) found that 
uncontrolled high blood pressure is a significant determinant for readmission in elderly 
patients with heart failure. In addition, the presence of hypertension prompts health care 
providers to use certain medications or special devices to minimize the complications of 
uncontrolled high blood pressure, consequently, reduce the chance for HF 
rehospitalization.  
Coronary artery disease is believed to cause HF with the presence of hypertension 
(Go et al., 2014). Generally, coronary artery disease with HF increases the chances for 
lethal events and mortality (Metra et al., 2011). In addition, it is linked to a significant 
increase in the chances of rehospitalization in patients with HF. For example, African 
Americans with HF who suffer from angina pectoris during hospitalization were found to 
have a significantly heightened chance for readmission within the first year after 
discharge (Muzzarelli et al., 2010; Ofili et al., 1999). If a patient had a myocardial 
infarction during the course of hospitalization, the likelihood for rehospitalization in the 
first 360 days after discharge increases significantly in HF patients (Blackledge et al., 
2003). Atrial fibrillation was identified as a predictor for rehospitalization when 
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associated with reduced or preserved ejection fractions in patients with HF (Ahmed, 
Thornton, Perry, Allman, & DeLong, 2004; T. Koitabashi et al., 2005; Ogah et al., 2014). 
Heart valve diseases among HF patients elevates the probability for readmission 
(C Berry et al., 2005; Ogah et al., 2014). Peripheral vascular disease is another 
comorbidity found to be related to increased HF readmission (Anand, Ventura, & Mehra, 
2007). In addition, peripheral vascular disease is responsible for increase loss of life and 
unplanned rehospitalizations (Metra et al., 2011). Aranda, Johnson, and Conti (2009) 
found that the presence of peripheral vascular diseases with HF increased the chance for 
readmission in HF patients 65 years and older. Cerebrovascular disease is linked to heart 
failure, mainly ischemic cerebrovascular disease. The chances for ischemic 
cerebrovascular disease increased with the presence of heart failure and HF 
rehospitalizations.  
Non-Cardiovascular Factors 
Several non-cardiovascular factors are linked with unplanned rehospitalizations in 
adults with HF. These factors are number of comorbidities, diabetes, anemia, chronic 
obstructive pulmonary disease (COPD), renal disease, pulmonary embolism, obstructive 
sleep apnea, and other conditions reflected by abnormal laboratory values (e.g. anemia 
and hyponatremia). 
The number of chronic conditions (comorbidities) was found to influence the 
rehospitalization rates especially in older adults with HF (Go et al., 2014). Diabetes and 
anemia were found to influence HF rehospitalization, as well as, chronic obstructive 
pulmonary diseases (COPD) and renal disease (Braunstein et al., 2003; Dunlay et al., 
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2009; Ogah et al., 2014). In a study by Aranda et al. (2009), it was noted that the 
antecedents for HF rehospitalization included the presence of one of these comorbidities 
with HF, such as, diabetes and renal disease. Moreover, renal disease was found 
significant in increasing 30-day rehospitalization in HF patients (Whittaker, Soine, & 
Errico, 2015). One of the major comorbidities reported in different studies to increase HF 
readmission was diabetes mellitus. The risk for readmission in HF patients who have 
diabetes increases significantly. In some cases, up to 28% of the HF patients (preserved 
>40% or reduced ≤ 40% ejection fraction) with diabetes were rehospitalized within 30-
day after discharge (Greenberg et al., 2007; H. M. Krumholz et al., 2000; MacDonald et 
al., 2008). Furthermore, anemia (lower than normal levels of red blood cells) was found 
to be associated with 30-day rehospitalization in HF patients (Felker, Adams, Gattis, & 
O'Connor, 2004; Muzzarelli et al., 2010). Anemic patients with HF (have hemoglobin 
level with less than 12 grams per deciliter) had heightened probability for 
rehospitalization within the first 30, 60, and 90-day after discharge (C. Berry et al., 2006; 
Ezekowitz, Bakal, Kaul, Westerhout, & Armstrong, 2008; Kosiborod et al., 2005; Luthi 
Jc, 2006; Young et al., 2008). 
The influence of COPD on HF patient has been evaluated, and COPD has 
increased HF readmission rates (C Berry et al., 2005; Braunstein et al., 2003; Harjai, 
Thompson, Turgut, & Shah, 2001; Howie-Esquivel & Dracup, 2007). Also, pulmonary 
embolism is a determinant for readmission in HF patients within three months (Darze et 
al., 2007). Finally, obstructive sleep apnea in HF patients multiplied the probability for 
rehospitalization to almost double, and the lack of compliance with the continuous 
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positive airway pressure (CPAP) therapy increased the chances for rehospitalization to 
almost four times (Kasai et al., 2008).  
Abnormal Laboratory Values  
Different laboratory values and associated conditions have shown to influence HF 
readmission. The level of hemoglobin was identified as one of the markers for early 
rehospitalization in patients with HF,  low level of hemoglobin at admission is linked to a 
higher risk for rehospitalization (Felker et al., 2003; Prasun et al., 2013; Young et al., 
2008). Increased hemoglobin in 20g/l was associated with a  28% decrease the chances 
for HF rehospitalization (C Berry et al., 2005). A lower level of hematocrit (percentage of 
red blood cells in blood) correlates significantly with higher rehospitalization rates 
(Kosiborod, Smith, Radford, Foody, & Krumholz, 2003).  
Hyponatremia (the low level of sodium) was identified as a determinant for 
readmission in HF patients within three months after discharge (Darze et al., 2007; Ogah 
et al., 2014), readmission within the first 180 days after discharge (Milo-Cotter et al., 
2008) , and rehospitalization within 12 months after discharge (Del Carlo, Pereira-
Barretto, Cassaro-Strunz, Latorre Mdo, & Ramires, 2004). In a study by M. Gheorghiade 
et al. (2007) it was noted that for every 3mmol/L increment reduction in level of sodium 
on admission (under 140 mmol/L), the chances for mortality and rehospitalization 
increased by 8% after discharge. Finally, the rise in the sodium level by 5 mmol/L during 
hospitalization was noted to correlate with 40% lower rehospitalization rates among HF 
patients (C Berry et al., 2005). 
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Liver function test, mainly, total bilirubin has been known to be a determinant for 
rehospitalization in HF patients (Shinagawa et al., 2008). Blood sugar levels during 
hospitalization is known to influence rehospitalization in HF patients with diabetes. Each 
two mmol/L rise in patient’s blood sugar level increases the chances for rehospitalization 
by eight percent (C. Berry, Brett, Stevenson, McMurray, & Norrie, 2008). An increase of 
one percent in the level of Hemoglobin A1c was found to increase the risk for 
rehospitalization in HF patients by twenty five percent (Gerstein et al., 2008). 
Additionally, the level of serum creatinine (marker of kidney function) was associated 
with rehospitalization in patient with the diagnoses of HF whether the ejection fraction 
declined or was conserved (Bettencourt et al., 2007; Prasun et al., 2013; Rodriguez-
Artalejo et al., 2006; Rodriguez-Artalejo et al., 2005). A rise in the level of blood urea 
nitrogen (BUN) is found to be associated with higher risk for HF rehospitalization (C 
Berry et al., 2005; Giamouzis et al., 2009; Sliwa et al., 2013) and uric acid was found to 
increase the chances for rehospitalization in males and females when it increased by 
7mg/dl and 6 mg/dl respectively (Niizeki et al., 2006). 
The value of natriuretic peptide has been identified as a marker for 
rehospitalization in HF studies, especially the level of B-type natriuretic peptide (BNP). 
The value of BNP when patients were admitted to the hospital or discharged was known 
to determine the probability of readmission in HF patients (Cheng et al., 2001; Ferreira et 
al., 2007; Gackowski et al., 2004; Valle, Aspromonte, Carbonieri, et al., 2008; Valle, 
Aspromonte, Giovinazzo, et al., 2008). A decline in the level of BNP is an indicator for 
improving patients outcomes and decreasing readmission rates (Bettencourt et al., 2007; 
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Bettencourt et al., 2004; Pimenta et al., 2007; Verdiani et al., 2008). In addition, the 
likelihood of HF readmission is found to be greater with an increase in the level of BNP 
(Wettersten et al., 2014). The level of cardiac Troponin (protein helps in identifying 
myocardial infarction) during hospitalization was a marker for rehospitalization in HF 
patients (Araujo et al., 2009; Ishii et al., 2003; Nishio et al., 2007; Perna et al., 2005; 
Verdiani et al., 2008). 
Medications 
The management of HF medications is challenging for both health care providers 
and patients as requires understanding the purpose of prescribed treatment, as well as, the 
associated side effects. The latest guidelines published by the American College of 
Cardiology/American Heart Association and the Heart Failure Society of America, 
indicated that the goal of HF therapy is to postpone, or prevent the damage to heart 
muscle, and in turn decrease deaths associated with HF using the combination of  
angiotensin converting enzyme (ACE) inhibitors and B-blockers (BB) (Lindenfeld et al., 
2010). HF patients are encouraged to follow the medication recommendations provided 
by their health care providers, and take the prescribed medications as scheduled. In 
addition, HF patients need to follow the directions of health care providers about 
avoiding selected medications as they increase the chances for exacerbation, such as, 
calcium channel blocker and NSAIDs (Hunt et al., 2009).  
Although the awareness related to controlling the comorbidities associated with 
HF, such as hypertension, is increasing, the rates of compliance with medications are not 
satisfactory (Roger et al., 2012). The use of anti-hypertensive medications play an 
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important role in controlling blood pressure and minimizing the associated complications, 
mainly, HF (Lenfant, Chobanian, Jones, & Roccella, 2003). The process of preventing 
HF by controlling hypertension or other risk factors can be reflected significantly in 
reducing the costs of treating HF patients (Daviglus, Lloyd-Jones, & Pirzada, 2006). 
The use of pharmacological and non-pharmacological therapies to treat HF has a 
significant influence on HF rehospitalization rates (H. Bueno et al., 2010). The odds for 
readmission in HF patients rise with the increase in the number of discharge medications 
(Wettersten et al., 2014). Multisite large studies have revealed that prescribing one of 
these medication classes, such as, (ACE) inhibitors, angiotensin II receptor blockers 
(ARBs), or (BB) at discharge, can reduce 60 to 90 day HF rehospitalizations rates 
(Corrao et al., 2015; C. Fonarow et al., 2007). Therefore, the current recommendation by 
the American College of Cardiology Foundation and American Heart Association 
encouraged the use of ACE inhibitors (help in reducing blood pressure) if tolerated in all 
patients with a history of myocardial infarction and low ejection fraction to prevent HF. 
If the use of ACE inhibitors is not permissible, then health care providers are encouraged 
to use ARBs (Yancy et al., 2013). 
In general, the use of ACE inhibitors, ARBs, and BB in treating HF patients aims 
to slow the heart muscle deterioration and help in managing the associated symptoms. 
The use of beta-blocker in HF patients aims to reduce the influence of catecholamine, 
such as, epinephrine and norepinephrine, which intensify the amount of work done by the 
heart, and over time improve the functionality of heart’s muscle (Yancy et al., 2013). 
Beta-blockers lowers heart rate, and cardiac output, consequently, decreases blood 
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pressure. Diuretics are another class of drugs used in HF patient population to remove the 
extra fluid and sodium from the body and lessen generalized and peripheral edema. 
Diuretics help in reducing the symptoms associated with HF, mainly, shortness of breath 
that result from fluid in the lungs. The use of diuretics to treat HF patients was found to 
be a significant determinant for 30-day HF rehospitalizations (Corrao et al., 2015). 
Finally, digitalis is used in HF patients to strengthen the contraction of heart muscle. 
Psychological Factors 
Psychological factors identified in the literature to influence HF rehospitalization 
include depression and anxiety. Depression is a common mental illness in adults with HF 
(Hägglund, Boman, Lundman, & Brulin, 2008). The prevalence of this condition in HF 
patients is increasing significantly (Albert & Zeller, 2009). HF and depression share 
different symptoms, and the presence of depression known to worsen the signs and 
symptoms of HF. Moreover, the associated symptoms, such as fatigue was found to 
increase the chances for HF rehospitalization (Song et al., 2009) and mortality 
(Johansson, Dahlström, & Alehagen, 2007; Macchia et al., 2008). In a study by Song et 
al. (2009) it was suggested that approximately 25% of the participants with a diagnosis of 
depression were readmitted to the hospital. A different study by Albert and Zeller (2009) 
found that among the 219 participants in the study, slightly less than half of the 
participants had depression associated with HF. The same authors reported that regardless 
of the increase in the level of depression, the belief that HF can be controlled was not 
associated with the increase in the level of depression. The conclusion was that HF 
patients are recognizing the presence of depression, yet they are unable to regulate it. 
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Depression was found to influence the level of self-care in HF patients. Generally, HF 
patients who are diagnosed with depression showed a lower ability to care for 
themselves, which results in other heart complications and increased rehospitalization 
rates (Holzapfel et al., 2009). Anxiety has been addressed in the HF literature with more 
than one study indicating that anxiety is linked to HF rehospitalization. In a study 
conducted by Volz et al. (2011) to assess the influence of several psychological 
conditions on HF rehospitalizations, severe anxiety was significantly linked to HF 
rehospitalizations. In another study by Amarasingham et al. (2010), it was implied that 
depression and anxiety were among the factors that determines 30-day HF 
rehospitalizations. 
Role Function Factors 
Socioeconomic status (SES), a role function factor, had influence on HF 
rehospitalization. A study of medical records for Medicare and Medicaid beneficiaries 
admitted to the hospital with the diagnosis of HF showed that there is an association 
between SES and both quality of care, and 30-day mortality. Moreover, one-year 
mortality and the risk of patient readmission were significantly higher in patients with 
lower SES (Rathore et al., 2006). Lower SES was significantly associated with increase 
in HF readmission (F. Philbin et al., 2001). A research study conducted by F. Philbin et 
al. (2001) indicated that the lower income in HF patients, was related to higher 
rehospitalization rates. In addition, the type of health insurance (Medicare, Medicaid, or 
private insurance) was linked to unplanned readmission for HF patient. Allen, Smoyer 
Tomic, Smith, Wilson, and Agodoa (2012) published a report comparing avoidable HF 
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readmission rates in patients with Medicaid versus commercial insurance. Those authors 
noted that the rates of readmission were greater in Medicaid beneficiaries and persons 
younger than 65 years. In addition, readmission rates for both Medicaid and private 
insurance beneficiaries were lower than for Medicare beneficiaries. Unemployment in HF 
patients significantly increased the chances for rehospitalization (Tsuchihashi et al., 
2001). Moreover, it was found that when HF patients have limited family support and 
live by themselves, smoke, and consume alcohol, their risk for rehospitalization increases 
significantly (Evangelista et al., 2000). 
Education and patient’s level of knowledge were found to be significant factors in 
predicting rehospitalization in HF patients (Keri, Cathleen, Galen, Ali, & Robert, 2008). 
The educational level and income were both major factors that affected the level of self-
care in elderly with HF (K. Moser & Watkins, 2008). The current generations of elderly 
have a lower educational level than other age groups, which may decrease adherence to a 
better and healthier self-care activities and lifestyle. This lack of adherence may increase 
their risk for readmission and lower quality of life (van der Wal et al., 2006). 
Current Knowledge and Gaps in the Literature 
HF and the associated readmissions have been a major focus by a great deal of 
researchers in this field. The influence of the unplanned rehospitalizations among HF 
patients has continued to be a major concern for patients and their families, caregivers, 
and health care systems. HF influences key aspects of a patient’s life, including the 
financial, emotional, psychological, and physical aspects (Giamouzis et al., 2011). 
Studying HF has led to an increase in the knowledge about HF and while the associated 
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treatment modalities have contributed to a significant increase in positive health 
outcomes, like improved HF disease management and better strategies in preventing HF 
readmission. HF is a condition that requires a great amount of collaboration between 
multiple disciplines, including health care providers, nurses, physical therapist, 
occupational therapist, pharmacist, and dietitians. Health care providers have a vital role 
in HF management and readmission prevention. In addition, providers play a major role 
in reducing patients’ length of stay, providing high quality care when symptoms 
exacerbate, as well as relieving patients’ pain associated with HF, safely discharging 
patients to appropriate setting, and minimizing HF unplanned rehospitalizations 
(Giamouzis et al., 2011).  
Typically, health care providers who treated HF patients utilized knowledge from 
the latest research, standards, and evidence-based practices. The use of those practices to 
guide the care for HF patients significantly reduces the probability of undesirable 
outcomes, such as mortality, lower level for quality of life, and readmissions (Yancy, 
2000). However, selected studies have shown that even when HF patients follow 
instructions and were compliant with the treatment regiment, health outcomes such as 
readmission, self-care, quality of life, morbidity, and mortality did not change or improve 
consistently. This phenomenon may have occurred because interventions provided did 
not account for the uniqueness of each HF patient (de Lusignan, 2001; Lorig K, 1985; 
Neily et al., 2002).  
The literature focused on identifying different factors that influence HF 
rehospitalizations as a foundation for successful interventions to reduce the rates of 
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unplanned rehospitalizations. The early identification of those factors has continued to 
play a major part in developing a successful discharge plan that addresses the needs of 
HF patients to many researchers. Studies have examined HF rehospitalization among 
different samples at multiple points after discharge (7, 30, 90, 180, and 360 days), using 
different designs, and different sets of variables or factors in each study. However, in 
clinical settings, health care providers have lacked consistent understandings of 
interventions that significantly reduced unplanned HF rehospitalizations. 
Studies about HF rehospitalization have been emerging, and yielded contradictory 
results. For example, some studies noted that age influenced HF rehospitalization; 
whereas others reported that age has no influence. The inconsistency in those results 
decreased the ability to generalize findings, and develop interventions. Generally, it is a 
complex process to determine patients at higher risk for rehospitalization, because each 
HF patient is a unique individual, in addition, the measures and instruments used on one 
sample might not be valid for different groups of HF patients. Therefore, factors that 
influence unplanned rehospitalization in HF patients need to be explored, to ascertain an 
agreement of what increases the occurrence of 30-day unplanned rehospitalizations. 
Accordingly, health care providers can target those factors, and develop interventions to 
reduce HF 30-day unplanned rehospitalizations. 
With the large amount of studies that aim to identify factors that influence HF 
rehospitalization, recognizing the precise factors was challenging (Giamouzis et al., 
2011). The current literature had three main areas that required further investigation. 
These areas included the presence of comorbidities and their influence on HF, the 
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influence of  non- medical factors (for instance: compliance with diet, exercise and 
medications) on HF patients, and the evaluation and management of HF exacerbation 
(Giamouzis et al., 2011). 
The presence of multiple comorbidities besides HF, such as, COPD might 
intensify the signs and symptoms of HF or completely cover them. With multiple 
comorbidities, it becomes more challenging to focus on treating HF only and ignore the 
other conditions, such as diabetes. Moreover, the presence of multiple comorbidities 
makes it harder on health care providers to identify the actual factors that increase the 
chances for HF rehospitalization. Therefore, this study included multiple identified 
comorbidities to have better understanding for the 30-day unplanned rehospitalizations in 
HF patients. 
The other gap in the literature identified in the prediction of HF rehospitalization 
was the focus on different outcomes beside HF. Studies have concentrated on mortality 
with rehospitalization or addressed HF rehospitalization as an outcome using different 
methods: the first method was studying HF with other cardiovascular and non-
cardiovascular conditions. This was called all cause rehospitalizations. The other method 
for studies was HF as an outcome within a group of single cardiac conditions only, such 
as MI. As a final point, the last method identified was to study HF only as an outcome 
without the consideration of other outcomes. The variations in studying HF without 
considering other conditions limits the generalizability of those results (Giamouzis et al., 
2011). 
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The final gap in the literature was the variation in the time period when the 
incident of HF rehospitalization occur, and the connection to different interventions 
developed to prevent unplanned rehospitalizations. Some studies addressed 
rehospitalization within the first week after discharge, while other studies have focused 
on 14, 30, 90, 180, and 360 days post discharge. Usually the interventions for HF patients 
rehospitalized within the first month were different from interventions designed to 
address HF patients rehospitalized within longer time periods. Commonly, the time after 
HF patients were discharged might indicate the area that needs more consideration by 
health care providers to prevent HF rehospitalization. For example, when researchers 
were trying to study unplanned rehospitalization in HF patients within 7-30 days, the 
evaluation of the hospitalization period should be considered. Therefore, this study 
included, contextual factors (patient characteristics), physiological factors (conditions, 
diagnoses, laboratory values and medications), psychological factors (depression and 
anxiety), and role function factors (patient’s living situation, marital status, insurance, 
and employment status) during the period of hospitalization. This approach provided a 
more clear understanding of the factors that influenced (increased or decreased) 
unplanned rehospitalization in HF patients.  
Summary 
HF was addressed in the literature, with few studies focusing on an age span of 
adults. Factors such as, patient’s characteristic, physiological factors, psychological 
factors, and role function factors were identified to influence HF readmission rates, yet, 
the rates are increasing significantly. It could be that the factors identified in one study 
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vary based on the location of the sample and settings, as well as, the characteristics of 
that sample. Alternatively, different combinations of factors under study may have 
contributed to the inconsistency in results reported. Therefore, identifying the factors that 
increased the chance for 30-day HF unplanned rehospitalizations in a specific setting 
(hospital) was important. Health care providers should be encouraged to identify those 
patients at higher risk for 30-day HF unplanned rehospitalization, identify the factors that 
lead to higher percentages of 30-day HF unplanned rehospitalization, and develop 
tailored interventions to reduce 30-day HF unplanned rehospitalization. 
When health care providers better understand the factors (e.g. patient’s 
characteristic, physiological factors, psychological factors, and role function factors)  that 
significantly influence patient’s adaptation, and increase the risk for 30-day HF 
unplanned rehospitalizations (maladaptation), they participate in the process of saving 
health care systems from wasting billions of dollars. The saved money could be used in 
other areas such health promotion and disease prevention. Therefore, this study was 
conducted in an acute care setting using a sample of adults with HF. The factors included 
in the study included contextual factors (patient’s characteristics), physiological factors, 
psychological factors, and role function factors.
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CHAPTER III
 
METHODOLOGY 
 
 
Research Design 
The design for this study was a descriptive retrospective design. The main 
independent variables in the study were patient’s characteristic, physiological factors, 
psychological factors, and role function factors, and many of those variables could not be 
ethically manipulated (Polit & Beck, 2012). The primary outcome in this study was the 
maladaptation of HF to the independent variables, which resulted in a 30-day unplanned 
rehospitalization. The retrospective nature of the study means that a current phenomenon 
(30-day unplanned rehospitalization in HF patient) was explored using existing data  
(Polit & Beck, 2012). 
Setting 
The study took place in an urban hospital that served a number of counties in 
central and western North Carolina. The hospital served an approximately 200,000 
resident area. In this hospital, HF was the number one diagnosis with the highest 
rehospitalization rates within the first 30 days after discharge (up to 48%). The hospital 
serves a county in which heart disease was a leading cause of death in white males. The 
average age in this county was 39.2 years and the median income was estimated at 
$42,000 per year. The major reported ethnicities were white (79%) and black (15%). 
Only twenty-nine percent of the residents 25 years of age and older had a high school 
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diploma, 18% had a bachelor’s degree, and 5% of persons had a graduate degree. 
Eighteen percent of the residents lived at the poverty line (Department of Social Services, 
2013).  
Sample 
A convenience sample was used to answer the primary research questions. 
Records of patients 21 years and older discharged from the hospital with a primary 
diagnosis of HF, and an International Statistical Classification of Disease and Related 
Health Problems (ICD-9) codes 428.0, 428.1,428.20,428.21,428.22,428.23,428.31, and 
428.32 during a three year period (2013-2015) were used. The principal investigator was 
provided with a list of medical record and encounter numbers for heart failure patients 
who were rehospitalized and not rehospitalized within the past three years, based on the 
criteria of inclusion and exclusion set by the investigator. A total number of 270 
participants was the final sample size for the study. 
The inclusion criteria were:  
Discharged with the ICD-9 code that represent HF   
Twenty-one years of age and older.  
Discharged alive from the hospital.  
And all HF (ICD-9 code) persons rehospitalized within 30-days after 
discharge.  
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The exclusion criteria for the patients in this study include: 
Twenty years of age or younger.  
Admission to the hospital under observation status. 
Discharged to hospice or deceased. 
The sample provided ample size to answer the research questions.  A total number 
of 138 HF patient records showed unplanned rehospitalization occurred within the past 
three years. Furthermore, to review the factors associated with the outcome variable 
(unplanned 30-day rehospitalization or not), a total number of records for 132 HF patients 
who had not been rehospitalized within 30-days were included.  The sample met the 
recommendation by (Voorhis & Morgan, 2007) that when using six or more predictors 
(independent variables) the absolute minimum of participants should be 10 per predictor.  
Further, using Peduzzi, Concato, Kemper, Holford, and Feinstein (1996) formula for 
logistic regression, the sample figures yielded N = 10 (k) / p in the most complex model, 
15 covariates with .48 positive cases in the population, thus the minimum number of 
cases required was N = 10 x 15 / 0..48 = 312. If the most complex model was using 12 
covariates with .48 positive cases, N = 10 x 12 / 0.48 = 250.  
 
Table 1. Sample Size Estimations 
 
# of Covariates or 
independent 
variables 
Smallest 
proportion of 
negative or positive 
cases 
Calculation Sample size 
required 
15 0.48 10 x 15 /0.48 312 
12 0.48 10 x 12 /0.48 250 
10 0.48 10 x 10 /0.48 208 
NOTE: Based on Peduzzi, et al (1996) recommendations and formula for logistic 
regression. 
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Data Collection 
The main independent variables included in the study were patient’s 
characteristics, physiological-physical mode, self-concept mode, and role function mode 
factors (appendix 2). The main dependent variable in this study is 30-day unplanned 
rehospitalization in HF patients as maladaptation. 
The PI accessed and extracted electronic medical records of HF patients for a 
three-year period. The source of data included, history and physical (H&P), progress 
notes, physicians consults, therapy consults, medication administration records (MAR), 
nursing assessment, nurse notes, case management assessment, case management notes, 
laboratory reports, radiology reports, and cardiology reports. The PI linked a unique ID 
number with the each medical record and encounter number. The PI accessed the list of 
eligible participants provided, since hospitals usually track HF patients and 
rehospitalization as a quality measure. 
The hospital used electronic medical records; therefore, the investigator was 
granted access to patient’s EMR for study data. A checklist developed by the PI used to 
facilitate the process of data collection from the electronic medical records (appendix 1). 
The electronic medical records that met the criteria for inclusion were reviewed for 
completeness and to avoid duplication of patients. Independent variables were collected 
on each patient as available. Data were extracted from the electronic medical records by 
the investigator at the hospital. All variables except insurance status (principal payer), 
discharge disposition and days between encounter pair (only in rehospitalized HF patient) 
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were hand extracted onto data collection forms with variable codes for numeric values 
and written text for string variables. 
The investigator randomly checked the study data forms for match with electronic 
medical record information. Then, the data were double-entered into an Excel 
spreadsheet. Data were saved on a secure hospital laptop computer with double password 
protection and secure software access, and data were crosschecked for accuracy. After all 
data were input, downloaded and checked, a random number was determined to select 
10% of the cases for a second accuracy check across all variables.  Finally, the 
dissertation committee member randomly selected 10% of the cases, as well as any 
outliers, to review.  Less than 0.1% of the data had errors to be fixed. After the PI 
finished data collection and cleaning, the excel data were exported to (SPSS v. 23) and 
checked for accuracy and final coding prior to analysis (SPSS Inc., Chicago, IL). 
Confidentiality was maintained throughout the research process to the extent 
permitted by the law and the IRB. Health Insurance Portability and Accountability Act 
(HIPAA) guidelines and rules in the process of data collection were followed.  All data 
were securely stored in firewalled, password protected computers or servers for electronic 
data and a locked cabinet accessible only through two ID secured doors. 
Reliability and Validity 
The conceptual framework and the adaptive modes guided the selection of 
variables.  Specific indicators within each mode were consistent with health indicators 
and outcomes used were similar to those used in the National Health Interview Survey, 
the National Health and Nutrition Examination Survey, and the National Quality 
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Measures Clearing house. Similarly, the variables, data points and their specific values 
and categories were those used by Centers for Disease Control and Prevention, the Center 
for Medicare and Medicaid Services, the American College of Cardiology and the 
American Heart Association.  In general, based on the range for normal values provided 
by the hospital, the PI determined whether a given laboratory values were normal or 
abnormal. To facilitate the process of identifying drug classes, the PI listed the main 
medications under each class type, and then determined if HF patient was taking any of 
these medications over the course of hospitalization.  
Data Analysis Plan 
There were 270 HF patients in this retrospective study. The PI recoded certain 
variables in an effort to meet the assumptions of statistical analyses. Descriptive statistics 
and univariate analysis were completed, and the results include means ± standard 
deviation (SD) for variables, such as, age, length of stay, body mass index, ejection 
fraction, number of previous hospitalizations within the past three years, difference 
between weight on discharge from weight on admission, and a number of laboratory 
values. In addition, frequencies and percentages for variables, such as, gender, race, 
marital status, living situation, the presence of certain diseases and conditions, New York 
Heart Association for HF classification, employment status, and the use of certain 
medications were described. 
First, the continuous variables were checked for normality. Three variables were 
normally distributed, and these included the level of hemoglobin on admission, the level 
of hematocrit on admission and at discharge. For the normally distributed variables, a t-
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test was performed between continuous variables, and the categorical variable 
(rehospitalized /not rehospitalized). When the assumption for the t-tests was not met, a 
Mann-Whitney U test was used to evaluate the individual relationships between the 
independent variables and dependent variable (rehospitalized /not rehospitalized). 
The goal of the statistical analysis was to explore the relationship between the 
outcome, 30-day unplanned rehospitalization in HF patients (dependent variable), and the 
associated factors (independent variables) including patients’ characteristics, 
physiological factors, psychological factors, and role function factors. The PI computed 
descriptive statistics initially to calculate measures of central tendency, such as 
frequency, mean, and standard deviation, for all variables. The continuous variables were 
checked for outliers and normality in univariate analysis using boxplots, normal P-P 
plots, and Kolmogorov-Smirnov tests. A two-sided p-value ≤ 0.05 was considered 
statistically significant.  
The pattern of missing values was assessed and examined because the number and 
trends of missing data could have major influence on the results of a given study 
(Bilheimer & Klein, 2010; Bilheimer & Sisk, 2008). For this study, missing data from the 
electronic medical records was in two forms. Laboratory values for some patient records 
were not present on the level of uric acid on admission and discharge, C-reactive protein, 
and troponin T because none had been ordered. Other missing data followed no pattern 
and was less than 0.1% of the data points. The final technique was to consider deleting 
the participant who has missing values from the study, which would have significantly 
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reduced the number of participants (Bilheimer & Klein, 2010). No cases were identified 
with missing data to be deleted in the analyses. 
Transformations or imputations were considered but none were necessary. For a 
few outliers, analyses were run with and without the outliers. If the analysis results did 
not change, the PI kept the outliers and used standardized scores or computed non-
parametric statistics.  
The first research question in this study was analyzed first using bivariate 
correlations and chi square analysis, and the second level of analysis used logistic 
regressions.  The assumptions were checked before running the analyses. This statistical 
test was used to model the relationship between 30-day unplanned rehospitalization, and 
contextual stimuli (patient’s characteristics, such as, gender, race, length of stay, 
residency area, BMI, number of previous hospitalizations, difference in weight between 
discharge and admission, and NYHA). The reason behind using logistic regressions was 
the ability to identify if multiple factors including continuous and categorical variables 
were determinant for 30-day unplanned HF rehospitalization.  
The second research question in this study was analyzed using two levels similar 
to question number one.  Initial analysis was bivariate in nature, followed by logistic 
Regression modeling. This last statistical test was used to model the relationship between 
30-day unplanned rehospitalization and physiological factors, such as, cardiovascular and 
non-cardiovascular conditions, laboratory values (normal or abnormal), and the types of 
cardiac related medication. 
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The third research question in this study was analyzed similar to the first two 
questions with a bivariate level and then logistic regression modeling. This last statistical 
test was used to model the relationship between 30-day unplanned rehospitalization and 
psychological factors, such as depression, anxiety. 
The fourth research question in this study followed the same pattern of analysis 
used in the first three question.  The bivariate analysis was completed and followed by 
the logistic regression to model the relationship between 30-day unplanned 
rehospitalization, and role function factors or patient’s living situation, marital status, 
insurance, and employment status.  
The fifth research question was answered using logistic regressions to model the 
combined relationship between 30-day HF unplanned rehospitalization and selected 
variables contextual factors of patients’ characteristics, physiological factors, 
psychological factors, and role function mode factors. 
Institutional Review Board (IRB) 
An agreement between the doctoral student as the Principle Investigator (PI) and 
the director of research in an urban hospital located in western North Carolina was 
signed. The agreement granted the PI an access to the electronic medical records for 
different data points. The type of data and different data collection procedures were 
included in the agreement between the PI and the director of research in that hospital. In 
addition, the PI obtained an IRB approval from the hospital and the University of North 
Carolina at Greensboro. Furthermore, all the policies and guidelines proposed by the 
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hospital were followed in the process of data collection. Data were protected through 
several steps for data security and to prevent deductive de-identification. 
Summary 
This descriptive retrospective study was designed to evaluate the influence of 
different factors such as, patients’ characteristics, physiological factors, psychological 
factors, and role function factors on 30-day unplanned rehospitalization in HF patients. 
The sample size was 270 patient EMR records from a regional hospital. Data was 
extracted and coded using Excel and SPSS.  Analyses included measures of central 
tendency, examination of variable distributions and normality. Bivariate correlations and 
chi square, as well as logistic regression, were used to answer the research questions that 
examined the relationships between multiple factors and 30-day HF unplanned 
rehospitalization. IRB was obtained from the hospital and the university. Data 
agreements were signed. Compliance with HIPAA and data security were followed.  
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CHAPTER IV 
 
RESULTS
 
 
The purpose of this study was to assess the influence of patient’s characteristics, 
physiological factors, psychological factors, and role function factors on 30-day HF 
unplanned rehospitalization in a sample drawn from a small urban area hospital in North 
Carolina. Data for this study were comprised of patient electronic medical records. Data 
were extracted electronically and manually into an Excel spreadsheet for 270 patients 
admitted with a HF diagnosis during 2013-2015. After accuracy and missing data checks, 
the data were transferred to SPSS V.23 to run the statistical analysis required to describe 
the sample and answer the research questions. In this chapter, the results of this study 
were discussed and explained. 
Sample Characteristics 
The mean age for HF patients included in this study was 68 (SD = 13.4) years. 
The average length of stay at the hospital for this sample was 5.11 (SD = 3.2) days, and 
the average body mass index for HF participants in this study was 32.60 (SD = 9.83).  
Overall, more than half of the HF patients included in this study were males, and more 
than three-fourths of the sample was white (Table 2). In addition, almost half of the HF 
patients were rehospitalized within 30 days (49%). Urban residents out-numbered rural 
residents.  Two-thirds of the HF patients had three or less inpatient hospitalizations 
within the past 3 years. The difference between admission weight in kilograms and the 
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discharge weight in kilograms was calculated. A majority (81.7%) of the participants in 
this study encountered weight loss, and 18.3% of the participants had no change, or 
gained weight during hospitalization. Finally, in terms of NYHA classification, class III 
(48%) and IV (27%) were more predominant among HF patients than class I and II. 
 
Table 2. Sample Characteristics (N = 270)   
 
Characteristic n (%) 
Gender 
        Female  
        Male         
 
130 (48) 
140 (52) 
Race 
        White 
        Black 
        Hispanic 
        Native American    
 
211 (78.1) 
54 (20) 
  1 (0.4) 
  2 (0.7) 
HF Rehospitalization 
        Rehospitalized  
        Not Rehospitalized   
 
138 (51) 
132 (49) 
Zip code 
        Rural  
        Urban  
 
   44 (16.3) 
  226 (83.7) 
Number of previous inpatient hospitalization 
        Three times or less 
        Four times and more 
 
180 (66.6) 
90  (33.4) 
Difference between weight on discharge and 
weight on admission 
        Encounter weight loss  
        No weight change  
        Encounter weight gain 
 
 
201 (81.7) 
 4 (1.6) 
41 (16.7) 
NYHA Classification  
        Class I 
        Class II 
        Class III 
        Class IV    
 
 6 (2.2) 
 49 (18.1) 
130 (48.1) 
  72 (26.7) 
NOTE:  frequency totals may not equal 100% due to missing responses or rounding. 
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First Research Question 
Research question number one was concerned with the relationship between the 
patient characteristics (contextual factors) and 30-day HF unplanned rehospitalization or 
no 30-day HF rehospitalization. With respect to patient characteristics, the NYHA 
classification had a statistically significant association with 30-day unplanned 
rehospitalization, meaning that the advance in NYHA is associated with a higher risk for 
30-day HF unplanned rehospitalization. There were no statistically significant 
relationships using chi square analysis between 30-day unplanned rehospitalization and 
gender, race, rural/urban residence (Table 3). 
 
Table 3. Bivariate Relationships between Patient Characteristic and 30-Day Unplanned 
Rehospitalization (N = 270) 
 
Variable Chi square 
Gender  P = 0.55 
Race  P = 0.44 
Rural/Urban P = 0.41 
NYHA  (X
2
=9.30), P = 0.026* 
*P<0.05 
 
 
With reference to other patient’s characteristic, the age of the participants and the 
length of stay were not statistically significant using Mann-Whitney t-test. On the other 
hand, the body mass index, the number of previous hospitalization within the past three 
years, and the difference in weight between discharges were significantly related to and 
higher in rehospitalized HF patients compared to none rehospitalized HF patients (Table 
4). 
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Table 4.  Bivariate Relationships between Patient Characteristic and 30-Day Unplanned 
Rehospitalization (N = 270) 
 
Variable  Mann- Whitney t-test 
Age  U(8501), P= 0.340 
Length of stay U(8053), P= 0.090 
BMI U(7284), P= 0.006* 
Number of previous hospitalizations U(5555), P= 0.001* 
Difference in weight between discharge and 
admission. 
U(6323), P= 0.020* 
*P<0.05 
 
 
For the second level of analysis in this question, patient’s characteristics of age, 
gender, race, length of stay, Rural/Urban, BMI, number of previous hospitalizations, 
difference in weight between discharge and admission, and NYHA classification were 
included in the logistic regression model. The model and observed data were not 
significantly different, thus the model was a good fit in understanding how the patient 
characteristics are related to 30-day unplanned hospitalization.  Length of stay, number of 
previous hospitalizations, difference in weight between discharge and admission, and 
NYHA classification were significant predictors of whether a person experienced a 30-
day unplanned hospitalization.  Specifically, the likelihood of a 30-day unplanned 
rehospitalization increased by 11% for every additional day spent in the hospital. The 
odds increased 23.3% for each additional hospitalization during the 3-year period, Also, 
the odds of a 30-day unplanned rehospitalization were 8.2% lower for persons losing 
greater amounts of weight before discharge, and the odds were 63.2% lower in HF 
patients with NYHA II compared to NYHA IV classification, adjusting for other 
variables in the model (Table 5). 
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Table 5. Logistic Regression Analysis of Patient Characteristics and 30-Day Unplanned 
Rehospitalization (N = 228) 
 
Characteristics OR 95% CI p-value 
Gender 
       Male 
RC*
 
       Female  
 
- 
0.825 
 
 
0.445-1.530 
 
 
0.542 
Race  
       Non-Hispanic White
   
       Other
 RC
 
 
 
0.530 
- 
 
0.247-1.137 
 
0.103 
Residence  
       Rural 
RC        
       Urban  
 
- 
1.886 
 
 
0.865-4.111 
 
 
       0.110 
Length of stay 1.110 1.012-1.217 0.028* 
BMI 0.967 0.935-1.000        0.053 
Number of previous 
hospitalizations 
1.233 1.105-1.376 0.001* 
Difference in weight between 
discharge and admission. 
0.918 0.853-0.988  0.023* 
NYHA  
Class I  
Class II 
Class III 
Class IV
 RC
 
 
0.926 
0.368 
0.557 
- 
 
0.453-1.890 
0.145-0.932 
0.078-3.999 
 
 
0.832 
 0.035* 
0.561 
 
Hosmer & Lemeshow (X
2
=7.88), (df=8), (P = 0.444) 
^RC=reference category    
*P<0.05 
 
 
Second Research Question 
Physiological mode factors of health diagnoses including cardiovascular and non-
cardiovascular conditions, clinical laboratory values, and medication usage were 
considered and there were both significant and nonsignificant relationships. 
Cardiovascular and Non-Cardiovascular Conditions 
In terms of the presence of diseases and comorbidities other than HF, the majority 
of HF patients had hypertension (86%). Nearly half of the HF patients presented with 
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diabetes (53%) and a third of the participants had Atrial Fibrillation (Table 6). Forty-three 
percent of the HF patients included in this study had a diagnosis of coronary artery 
disease, and one-third had chronic obstructive pulmonary disease. Although 19% of the 
HF patients had been diagnosed with Obstructive Sleep Apnea, only 10% were using 
CPAP. In addition, close to one-fifth of the participants in this study had suffered a stroke 
in the past, and almost 11% of patients were anemic. Moreover, the proportion of HF 
patients with an ejection fraction equal to or less than 40 (reduced ejection fraction) was 
forty-three percent. 
 
Table 6. Cardiovascular Related Conditions and Variables among HF Participants (N = 
270) 
 
Characteristic n (%) 
Yes No 
The Diagnosis of Diabetes Miletus   142(52.6) 128(47.4) 
The Diagnosis of Hypertension  233(86.3) 37(13.7) 
The Diagnosis of Atrial fibrillation  89 (33) 181(67) 
The Diagnosis of Coronary artery disease   115(42.6) 155(57.4) 
The Diagnosis of Myocardial infarction  15(5.6) 255(94.4) 
The Diagnosis of Angina 2(0.7) 268(99.3) 
The Diagnosis of  Stroke  45(16.7) 225(83.3) 
The Diagnosis of Anemia 29(10.7) 241(89.3) 
The Diagnosis of  Chronic Kidney Disease  61(22.6) 209(77.4) 
The Diagnosis of Chronic Obstructive Pulmonary Disease 82(30.4) 188(80.7) 
The Diagnosis of Obstructive Sleep Apnea  52(19.3) 218(80.7) 
The use of CPAP 26(9.6) 244(90.4) 
Ejection fraction  
        Less than or equal 40(reduced) 
        More than 40 (preserved) 
 
118 (43.7) 
149 (55.8) 
NOTE:  frequency totals may not equal 100% due to missing responses and rounding. 
 
 
With respect to cardiovascular and non-cardiovascular conditions, the diagnosis 
of chronic kidney disease, and the use of CPAP in HF patients were statistically 
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significant related to 30-day unplanned rehospitalization. The presence of chronic kidney 
disease was associated with having 30-day HF unplanned rehospitalization. In addition, 
the use of CPAP was associated with having HF rehospitalization. The diagnosis of 
diabetes, hypertension, atrial fibrillation, Coronary artery disease, stroke, anemia, chronic 
obstructive pulmonary disease, sleep apnea, and ejection fraction were not statistically 
related to 30-day unplanned rehospitalization (Table 7). 
 
Table 7. Bivariate Relationships between Physiological Factors--Health 
Condition/Diagnosis and 30-Day Unplanned Hospitalization (N = 270) 
 
Variable  Chi square 
The diagnosis of diabetes P = 0.70 
The diagnosis of hypertension P = 0.74 
The diagnosis of A-fib P = 0.15 
The diagnosis of CAD P = 0.84 
The diagnosis of stroke P = 0.74 
The diagnosis of anemia P = 0.06 
The diagnosis of chronic kidney disease (X
2
=12.56), P = 0.001* 
The diagnosis of chronic obstructive pulmonary 
disease 
P = 0.98 
The diagnosis of obstructive sleep apnea P = 0.09 
The use of CPAP  (X
2
=7.67), P = 0.006* 
Ejection fraction  P = 0.731 
*P<0.05 
 
 
Physiological mode cardiovascular and non-cardiovascular conditions were 
included in this logistic regression equation for second level analysis. The conditions 
included diabetes, hypertension, atrial fibrillation, coronary artery disease, stroke, 
anemia, hyponatremia, chronic kidney disease, chronic obstructive pulmonary disease, 
and obstructive sleep apnea with the use of CPAP. The model and observed data were not 
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significantly different, thus the model was a good fit in understanding how the 
cardiovascular and non-cardiovascular are related to 30-day unplanned hospitalization. 
For health diagnoses and conditions including cardiovascular and non-
cardiovascular, there were statistically significant relationships between chronic kidney 
disease, use of CPAP and 30-day unplanned rehospitalization. Specifically, the odds 
increase for 30-day unplanned rehospitalizations were 2.94 in HF patient with chronic 
kidney disease. Additionally, the odds of a 30-day unplanned rehospitalization were 72% 
lower for persons who use CPAP machine adjusting for other variables in the model 
(Table 8). No significant relationships were found between a diagnosis of diabetes, 
hypertension, atrial fibrillation, coronary artery disease, stroke, anemia, chronic 
obstructive pulmonary disease or obstructive sleep apnea and 30-day unplanned 
rehospitalization. 
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Table 8. Logistic Regression Analysis of Health Conditions or Diagnoses and 30-Day 
Unplanned Rehospitalization (N = 267) 
  
Condition or diagnosis  OR 95% CI p-value 
Diagnosed with 
Hypertension   
0.699 0.329-1.488 0.353 
Diagnosed with Diabetes  
 
1.579 0.899-2.773 0.112 
Diagnosed with atrial 
fibrillation  
1.474 0.859-2.529 0.159 
Diagnosed with Coronary 
artery disease 
0.899 0.529-1.528 0.694 
Diagnosed with Stroke 1.041 0.532-2.037 0.907 
Diagnosed with chronic 
kidney disease 
2.940 1.541-5.611 0.001* 
Diagnosed with chronic 
obstructive pulmonary 
disease 
1.187 0.681-2.069 0.544 
Diagnosed with obstructive 
sleep apnea. 
0.751 0.356-1.585 0.452 
The use of CPAP 0.280 0.090-0.872 0.028* 
Hosmer & Lemeshow (X
2
=0.031), (df=1), (P = 0.861) 
*P<0.05 
 
 
Laboratory Values (Normal and Abnormal) 
The average of HbA1c (glucose control past three months) among HF patients 
was 7.3, meaning persons were in the diabetic diagnosis range (Table 9). In addition, 
50% of the medical records showed patients had a Brain natriuretic peptide (BNP) of 630 
or less, which showed an increase in ventricular secretion of this amino acid due to extra 
starching of the heart muscle, and meaning that HF was worsening in this group. More 
than six percent of the participants had a troponin I of less than or equal 0.01, indicative 
that there was no destruction to the heart muscle noted due to lack of coronary blood 
supply in this group. The average hemoglobin at admission upon discharge was slightly 
less than the normal range. The average level of hematocrit at admission and upon 
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discharge were within the normal ranges.  Furthermore, the average sodium, potassium 
and creatinine were within normal ranges at admission and discharge. Blood urea 
nitrogen (BUN) averaged slightly high at admission but within normal range upon 
discharge. 
 
Table 9. Laboratory Values for HF Participants (N = 270) 
 
Laboratory value Mean ± SD* 
 Admission  Discharge  
Hemoglobin  11.9 ± 2.1 11.6 ± 2.0 
Hematocrit  36.5 ± 6.2 35.1 ± 5.9 
Sodium  136 ± 4.4 136 ± 3.6 
Potassium 4.1 ± 0.6 4.1 ± 0.5 
Creatinine 1.5 ± 1.0 1.5 ± 0.9 
Blood Urea Nitrogen  26.0 ± 16.4 30.1 ± 15.5 
SD = standard deviation. 
NOTE:  frequency totals may not equal 100% due to missing responses and rounding. 
 
 
For the normally distributed hemoglobin on admission, the independent sample t-
test was associated with statistically significant effect. Thus, rehospitalized HF patients 
had higher average level of hemoglobin on admission than those persons not 
rehospitalized. For hematocrit on admission, the independent sample t-test was associated 
with statistically significant effect. Thus, rehospitalized HF patients had a statistically 
higher mean of hematocrit on admission than persons not rehospitalized. With respect to 
hematocrit at discharge, the independent sample t-test was associated with statistically 
significant effect. Thus, rehospitalized HF patients had a statistically higher average 
hematocrit at discharge than persons not rehospitalized (Table 10). 
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Table 10.  Relationships between Laboratory Values (Normally Distributed) and 30-Day 
Unplanned Hospitalization (N = 270) 
 
Variable  t (df),  p-value 
Hemoglobin on admission t=3.75 (264.4)  p=0.001* 
Hematocrit on admission t=3.93 (264.3)  p=0.001* 
Hematocrit at discharge  t=3.97(234.0)   p=0.001* 
*P<0.05 
 
 
The Mann-Whitney test was used to compare mean ranks between the laboratory 
values not normally distributed (mainly due to floor effect) and 30-day HF unplanned 
rehospitalization. The mean rank of hemoglobin level at discharge, creatinine level at 
admission and at discharge, blood urea nitrogen at admission and at discharge and B-type 
Natriuretic peptide in the rehospitalized group was statistically significantly higher than 
the not rehospitalized group (Table 11).  No significant relationships were found between 
sodium on admission, sodium at discharge, potassium on admission, potassium at 
discharge, hemoglobin A1C and 30-day unplanned rehospitalization. 
 
Table 11. Laboratory Values Mann-Whitney T-Test (N = 270) 
 
Laboratory Values Mann-Whitney t-test U , P-value  
Hemoglobin at discharge  U(5024),P=0.001* 
Sodium on admission U(8599),  P=0.426 
Sodium at discharge  U(8191), P=0.214 
Potassium on admission U(8039), P=0.095 
Potassium at discharge  U(8815), P=0.721 
Hemoglobin A1C U(2159), P=0.487 
Creatinine on admission U(6603), P=0.001* 
Creatinine at discharge  U(6887), P=0.001* 
Blood urea nitrogen on admission U(6908), P=0.001* 
Blood urea nitrogen at discharge U(7584), P=0.022* 
B-type Natriuretic peptide  U(6647), P=0.002* 
The level of troponin I U(8070), P=0.919 
*P<0.05 
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Laboratory values mainly at discharge were included in this logistic regression 
equation. The laboratory values included were hemoglobin at discharge, hematocrit at 
discharge, creatinine at discharge, sodium at discharge, potassium at discharge, B-type 
natriuretic peptide, and cardiac troponin I. The model and observed data were not 
significantly different, thus the model was a good fit in understanding how the laboratory 
values are related to 30-day unplanned rehospitalization. For laboratory values, there 
were statistically significant relationships between the level of B-type natriuretic peptide 
at discharge and 30-day unplanned rehospitalization. Explicitly, the odds increase for 30-
day unplanned rehospitalizations were even for each unit increase in the level of BNP 
(Table 12). No significant relationships were found between hemoglobin at discharge, 
hematocrit at discharge, creatinine at discharge, sodium at discharge, potassium at 
discharge, and cardiac troponin I and 30-day unplanned rehospitalization (Table 12). 
 
Table 12. Logistic Regression Analysis of Laboratory Values and 30-Day Unplanned 
Rehospitalization (N = 215) 
 
Laboratory Value OR 95% CI p-value 
Hemoglobin at discharge 0.915 0.507-1.649 0.766 
Hematocrit at discharge 0.964 0.786-1.182 0.725 
Creatinine at discharge
 
1.356 0.899-2.046 0.147 
Sodium at discharge 1.062 0.980-1.151 0.144 
Potassium at discharge 0.574 0.305-1.080 0.085 
B-type natriuretic peptide 1.000 1.000-1.001 0.050* 
Cardiac troponin I 0.487 0.015-15.614 0.684 
Hosmer & Lemeshow (X
2
=13.772), (df=8), (P = 0.088) 
*P≤ 0.05 
 
 
 
68 
Medications 
 
Medication classifications used in the treatment of HF patients in this study were 
examined. The main group of medications that was used in the majority of HF 
participants was loop diuretics (87%), with Furosemide being the most frequently used 
medication in the treatment regimen of HF patients (80%) (Table 13). The use of Beta 
Blockers was noted in 207 patients, with around three-fourths of the total sample. 
Carvediolol (43%) and Lopressor (31%) were the most frequently used Beta-blockers. 
The use of Angiotensin Converting Enzymes Inhibitors was noted in almost half of the 
participants (46%). The Angiotensin Converting Enzymes Inhibitors most frequently 
utilized in the treatment of this sample was Lisinopril. There was minimal use of 
Angiotensin II receptor blockers (ARB) to treat HF patients in this group. Only 9.3% of 
the participants were on ARBs and Losartan was most frequently used.  
 
Table 13. Common Medication Classifications Used for HF Participants (N = 270) 
 
Medication classification n (%) 
Yes No 
The use of loop Diuretics  235 (87) 35 (13) 
The use of Thiazides   15 (5.6) 255(94.4) 
The use of Potassium sparing diuretics    35(13) 235(87) 
The use of Beta Blockers    207(76.7) 63(23.3) 
The use of Angiotensin Converting Enzymes inhibitor  123 (45.6) 147 (54.4) 
The use of Angiotensin II receptor blockers 25(9.3) 245 (90.7) 
NOTE:  frequency totals may not equal 100% due to missing responses and rounding. 
 
 
The p-value of the Chi-square test between the rehospitalized\ not rehospitalized 
group and the use of angiotensin converting enzymes inhibitor showed that there was a 
statistically significant association between the rehospitalized\ not rehospitalized HF 
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patients and the use of angiotensin converting enzymes. This means that 30-day HF 
unplanned hospitalization were significantly associated with taking angiotensin 
converting enzymes inhibitors. No relationships existed for the use of loop diuretics, 
thiazides, potassium sparing diuretics, beta-blockers, the angiotensin II receptor blocker 
or anxiolytics and 30-day unplanned hospitalization (Table 14). 
 
Table 14. Bivariate Relationships between Medications and 30-Day Unplanned 
Hospitalization (N = 270) 
 
Medication classification Chi square 
The use of loop diuretics  P = 0.49 
The use of thiazides  P = 0.72 
The use of potassium sparing diuretics P = 0.96 
The use of beta-blocker P = 0.81 
The use of angiotensin converting enzymes inhibitor (X
2
=3.95), P = 0.047* 
The use of angiotensin II receptor blocker P=0.74 
*P<0.05 
 
 
In regards to medications, cardiac related medications were included in this 
logistic regression equation. The medications included were the use of loop diuretics, the 
use of thiazides, the use of potassium sparing diuretics, the use of beta-blockers, the use 
of angiotensin converting enzymes, and the use of angiotensin II receptors blockers. The 
model and observed data were not significantly different, thus the model was a good fit in 
understanding how the use of certain medications are related to 30-day unplanned 
hospitalization.   
For cardiac related medications, there were statistically significant relationships 
between the use of angiotensin converting enzymes and 30-day unplanned 
rehospitalization. Explicitly, the odds for 30-day unplanned rehospitalizations were 
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44.1% lower for HF patients on angiotensin converting enzymes (Table 15). No 
significant relationships were found between the use of loop diuretics, the use of 
thiazides, the use of potassium sparing diuretics, the use of beta-blockers, and the use of 
angiotensin II receptors blockers and 30-day unplanned rehospitalization. 
 
Table 15. Logistic Regression Analysis of Medication and 30-Day Unplanned 
Rehospitalization (N = 270) 
 
Medication classification OR 95% CI p-value 
The use of loop diuretics 0.763 0.369-1.579 0.446 
The use of thiazides 1.169 0.404-3.386 0.773 
The use of potassium sparing 
diuretics
 
1.144 0.549-2.385 0.719 
The use of beta-blockers 1.089 0.609-1.947 0.773 
The use of angiotensin 
converting enzymes 
0.559 0.360-0.998 0.049* 
The use of angiotensin II 
receptors blockers 
0.936 0.396-2.214 0.881 
Hosmer & Lemeshow (X
2
=4.713), (df=7), (P = 0.695) 
*P<0.05 
 
 
Third Research Question 
The psychological mode factors were the focus of the third research question. The 
presence of depression and anxiety were evaluated as variables that might have increased 
the chance for 30-day unplanned rehospitalization in HF patients. Depression and anxiety 
diagnoses were found in almost one-fourth of the participants (24%). In terms of 
antidepressants and anxiolytics, almost 15% of the HF patients were on antidepressants 
and almost 19% of patients were taking anxiolytics (Table 16). Furthermore, the result of 
this study showed that 61.5% of the participants diagnosed with depression were on 
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antidepressants. Similarly, all the participants diagnosed with anxiety were placed on 
some sort of anxiolytics.  
 
Table 16. Psychological Mode Factors in the Sample of HF Patients (N = 270) 
 
Characteristic n (%) 
Yes No 
The use of Antidepressant   41 (15.2) 229 (84.8) 
The use of anxiolytics  51 (18.9) 219 (81.1) 
The Diagnosis of Depression   65(24.1) 205(75.9) 
The Diagnosis of Anxiety   64(23.7) 206(76.3) 
NOTE:  frequency totals may not equal 100% due to missing responses or rounding. 
 
 
The p-value of the Chi-square test between the rehospitalized\ not rehospitalized 
group and the use of antidepressants is 0.017.  Therefore, we conclude that there is a 
statistically significant association between the rehospitalized\ not rehospitalized HF 
patients and the use of antidepressants. This means that 30-day HF unplanned 
rehospitalization is associated with the use of antidepressants. The p-value of the Chi-
square test between the rehospitalized\ not rehospitalized group and the diagnosis of 
depression and anxiety or the use of anxiolytics were not significant (Table 17). 
 
Table 17. Bivariate Relationships between Psychological Mode Factors and 30-Day 
Unplanned Hospitalization (N = 270) 
 
Factor  Chi square 
The diagnosis of depression P = 0.054 
The diagnosis of anxiety  P = 0.710 
The use of Antidepressant (X
2
=5.711), P = 0.017* 
The use of Anxiolytics  P = 0.770 
*P<0.05 
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The psychological mode factors were included in the logistic regression equation. 
The psychological factors included were the diagnosis of depression, the diagnosis of 
anxiety, the use of antidepressant, and the use of anxiolytics. The model and observed 
data were not significantly different, thus the model was a good fit in understanding how 
psychological factors are related to 30-day unplanned hospitalization.  However, there 
were no statistically significant individual relationships or specific predictors between the 
diagnosis of depression, the diagnosis of anxiety, the use of antidepressant, and the use of 
anxiolytics and 30-day unplanned rehospitalization when combined (Table 18). 
 
Table 18. Logistic Regression Analysis of Psychological Factors and 30-Day Unplanned 
Rehospitalization (N = 270) 
 
Factors OR 95% CI p-value 
The diagnosis of depression 0.880 0.330-2.353 0.800 
The diagnosis of anxiety 1.039 0.265-4.079 0.956 
The use of antidepressant
 
0.480 0.162-1.419 0.184 
The use of anxiolytics 0.928 0.230-3.739 0.916 
Hosmer & Lemeshow (X
2
=0.124), (df=2), (P = 0.940) 
 
 
Fourth Research Question 
The impact of the role function mode factors on 30-day rehospitalization in HF 
patients was addressed in research questions four using marital status, living situation 
(alone or not), employment status and insurance status. Twenty-two percent of the 
participants included lived alone. In term of marital status, almost half of the HF patients 
were married (47%), six percent of the HF patients were unemployed, and close to 96% 
of the participants had insurance coverage (Table 19).  
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Table 19. Role Function Mode Factors (N = 270) 
 
Characteristic n (%) 
Yes No 
Lives alone  61 (22.6) 209 (77.4) 
Marital Statues  127(47) 135(50) 
Employment status   15 (5.6) 255 (94.4) 
Insurance status  259 (95.9) 11 (4.1) 
NOTE:  frequency totals may not equal 100% due to missing responses and rounding 
 
 
The p-value of the Chi-square test between the rehospitalized\ not rehospitalized 
group and marital, employment, and insurance status showed significant associations. 
This means that 30-day HF unplanned rehospitalization was a dependent on the marital, 
employment, and insurance status of the HF patients (Table 20). On the other hand, there 
was no statistically significant association between the rehospitalized/ not rehospitalized 
HF patients and living situation. 
 
Table 20. Bivariate Relationships between Role Function Mode Factors and 30-Day 
Unplanned Hospitalization (N = 270) 
 
Role function mode factors   Chi square 
Living situation  P = 0.09 
Marital status  (X
2
=5.043), P = 0.025* 
Employment status  (X
2
=11.33), P = 0.001* 
Insurance status  (X
2
=4.327), P = 0.038* 
*P<0.05 
 
 
In question four, role function mode factors were included in the logistic 
regression equation. The role function factors included living situation, marital status, 
employment status, and insurance status. The model and observed data were not 
significantly different, thus the model was a good fit in understanding how role function 
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mode factors were related to 30-day unplanned hospitalization. There were statistically 
significant relationships between the living situation, marital status, and employment 
status and 30-day unplanned rehospitalization with consideration of all factors. 
Specifically, the odds for 30-day unplanned rehospitalizations were 57.9 % lower for HF 
patients living alone compared to HF patients who lives with someone. The odds for 30-
day unplanned rehospitalizations were more than twice as high for unmarried HF patients 
compared to married HF patients. Lastly, the odds for 30-day unplanned 
rehospitalizations were 92.7% lower for employed HF patients compared to unemployed 
HF patients. No significant relationships were found between insurance status and 30-day 
unplanned rehospitalization (Table 21). 
 
Table 21. Logistic Regression Analysis of Role Function Mode Factors and 30-Day 
Unplanned Rehospitalization (N = 262) 
 
Role function factor OR 95% CI p-value 
Lives alone 0.421 0.216-0.820 0.011* 
Not married  2.468 1.413-4.309 0.001* 
Employed  0.073 0.009-0.583 0.014* 
Insured  4.268 0.826-22.06 0.083 
Hosmer & Lemeshow (X
2
=0.031), (df=1), (P = 0.861) 
*P<0.05 
 
 
Fifth Research Question 
For this question, variables associated with or that predicted the 30-day unplanned 
from prior analysis in the research questions one through four were tested to build the 
final model of the combined influence of adaptive mode factors on the outcome. The 
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variables included in this logistic regression were length of stay, number of previous 
hospitalizations, difference in weight between discharge and admission, NYHA, the 
diagnosis of chronic kidney disease, the use of CPAP, BNP, the use of angiotensin 
converting enzymes inhibitor, the use of antidepressants, the living situation, marital 
status and insurance status. The model and observed data were not significantly different, 
thus the model was a good fit in understanding how patient characteristics, physiological, 
psychological, and role function factors were related to 30-day unplanned hospitalization. 
There were statistically significant relationships between the number of previous 
hospitalizations, difference in weight between discharge and admission, the use of 
angiotensin converting enzymes inhibitor, the use of antidepressants, and not being 
married and 30-day unplanned rehospitalization. Specifically, the likelihood of a 30-day 
unplanned rehospitalization increased by 30.2% for every additional previous 
hospitalization. The odds of a 30-day unplanned rehospitalization were 11.8% lower for 
persons losing greater amounts of weight between admission and discharge. The odds for 
30-day unplanned rehospitalization were 53% lower in HF patients on angiotensin 
converting enzymes inhibitors compared to HF patients not on angiotensin converting 
enzyme medications. The odds for 30-day unplanned rehospitalization were 76.6 % lower 
in HF patients on antidepressants compared to HF patients not on antidepressants. 
Finally, the odds for 30-day unplanned rehospitalization were more than twice as likely 
for unmarried HF patients compared to married HF patients, adjusting for and 
considering all variables in the model (Table 22).  No significant relationships were 
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found between length of stay, NYHA, the diagnosis of chronic kidney disease, the use of 
CPAP, BNP, living alone or insurances status and 30-day unplanned rehospitalization.  
 
Table 22. Logistic Regression Analysis of Variables from Patient Characteristics, 
Physiological, Psychological, and Role Function Modes and 30-Day Unplanned 
Rehospitalization (N = 219) 
 
Factor OR 95% CI p-value 
Length of stay 1.110 0.996-1.236 0.059 
Number of previous 
hospitalizations 
1.302 1.142-1.484 0.001* 
Difference in weight between 
discharge and admission 
0.882 0.813-0.957 0.003* 
NYHA I 
NYHA II 
NYHA III 
NYHA IV
RC
 
0.394 
0.441 
1.046 
0.036-4.349 
0.159-1.217 
0.471-2.325 
 
0.447 
0.114 
0.912 
 
The diagnosis of chronic 
kidney disease 
1.866 0.799-4.355 0.149 
The use of CPAP 0.251 0.059-1.059 0.060 
BNP 1.000 1.000-1.001 0.062 
The use of angiotensin 
converting enzymes inhibitor 
0.463 0.237-0.906 0.024* 
The use of antidepressants 0.234 0.083-0.659 0.006* 
Living alone 0.509 0.219-1.184 0.117 
Not married   2.319 1.136-4.732 0.021* 
Insured  5.212 0.767-35.40 0.091 
RC: Reference Category 
*P<0.05 
Hosmer & Lemeshow (X
2
=12.222), (df=8), (P = 0.142) 
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CHAPTER V
 
DISCUSSION 
 
 
Introduction  
The aim of this study was to evaluate the influence of contextual factors of 
patient’s characteristics, physiological factors, psychological factors, and role function 
factors on 30-day HF unplanned rehospitalization using electronic medical records from a 
small urban area hospital in North Carolina. The Roy Adaptation Model (RAM) guided 
the selection of variables and provided a framework for the findings. The author used this 
chapter to critically examine the findings of this study, link with previous knowledge, and 
discuss support for the conceptual model, nursing implications, conclusions, and 
recommendations for further research. 
The main sample characteristics or contextual factors in this study were similar to 
the characteristics reported in the literature. The mean age for the participants surveyed 
was 68 years, which is similar to what other studies suggest that older adults with HF 
were found to be at higher risks for readmissions (Ross et al., 2010). More than half of 
the patients were male, and no differences were found in 30-day unplanned 
rehospitalization between genders. 
More than half of the participants in this study were rehospitalized within 30 days 
after discharge from hospital. This sample was similar to prior patients studied, in that 
30-day unplanned rehospitalizations were documented in half of the participants (Joynt & 
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Jha, 2011; Harlan M. Krumholz et al., 2009; Setoguchi & Stevenson, 2009). In another 
study, rehospitalization was encountered in only 16-25% of  HF patients (Keenan et al., 
2008). The variation could be a result of the difference in the characteristics of patient 
samples, the geographic areas, and the community resources available to deal with 30-
day HF unplanned rehospitalization. For the current study, the number of HF patients 
from an urban area out-numbered HF patients from rural area, and the number of 
rehospitalized patients from an urban area was higher than from the rural area. This 
finding was unlike the previous reports that patients who lived in a lower income area, 
such as rural areas, had a higher risk for rehospitalization (F. Philbin et al., 2001). The 
non-Hispanic White group was the dominant group, which was similar to a study 
conducted by Hernandez et al. (2013). The majority of the patient medical records 
included in the study showed weight reduction during hospitalization and the most 
predominant NYHA were classes III and IV.  Both of these last two factors were 
expected based on HF physiology and diagnosis. 
The first research question examined the influence of patient’s characteristics on 
30-day HF unplanned rehospitalization. The NYHA classification and the body mass 
index were related to 30-day HF unplanned rehospitalization. Also, the number of 
previous hospitalization within the past three years, and the difference in weight between 
discharge and admission were found significantly associated with 30-day HF unplanned 
rehospitalized. The following factors were related in the combined factor examination 
length of stay, number of previous hospitalizations, difference in weight between 
discharge and admission, NYHA class II classification as significant predictors of 
 
79 
whether a person experienced a 30-day HF unplanned hospitalization. The result from 
this study showed that the NYHA classification was associated with 30-day unplanned 
rehospitalization. Specifically, class II was a predictor in decreasing the chances for 30-
day HF unplanned rehospitalization compared to class IV. This result was similar to the 
results of several previous studies (Feola et al., 2008; Toshimi Koitabashi et al., 2005; R. 
Lee et al., 2009). 
The increase in BMI was found significantly higher in rehospitalized HF patients 
compared to non rehospitalized HF patients. A previous study by Prasun et al. (2013) 
reported similar results of increased 30-day unplanned rehospitalization with increased 
BMI. The increased number of previous hospitalization within the past three years was 
related to greater rehospitalized HF patients compared to non-rehospitalized HF patients, 
and this finding was supported by previous studies (Darze et al., 2007; Felker et al., 2003; 
Gackowski et al., 2004). The difference in weight between discharge and admission as a 
predictor for HF unplanned rehospitalization, with the odds were lower for HF by losing 
higher amounts of weight before discharge, was similar to the study conducted by 
(Hernandez et al., 2013), that showed the odds of HF rehospitalization decreased when 
patients lost more weight before discharge. 
Length of hospital stay for HF patients was predictive of 30-day unplanned 
rehospitalization. Specifically, unplanned rehospitalization increased with longer length 
of stay. This finding was comparable to Tsuchihashi et al. (2001) report that the risk for 
HF rehospitalization increased. The result was different from the research conducted by 
(Héctor Bueno et al., 2010), that reported an increased rate of 30-day unplanned 
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rehospitalization with the decreased in length of stay. This may be due to a specific use of 
the Diagnosis-Related Group (DRG) payment system and moving patients out of the 
hospital quicker over the past decade. The new CMS rule regarding meeting metrics may 
provide more stability in the length of stay for HF patients and allow providers to 
discharge patients with their best health that will prevent 30-day unplanned 
rehospitalization. This study reported that NYHA classification, BMI, length of stay, 
number of previous hospitalizations within the past three years, and difference in weight 
between discharge and admission were linked to 30-day unplanned rehospitalization. 
This shows that 30-day rehospitalization was not related to physiological changes only; it 
was multidimensional phenomenon with several factors. Health care providers and nurses 
should evaluate multiple areas of HF patient health and lives before planning patient care 
and assessing readiness for discharge. 
The second research question was used to examine three groups of physiological 
factors on the outcomes. The initial analysis examined the influence of cardiovascular 
and non-cardiovascular conditions on 30-day HF unplanned rehospitalization. The 
proportion of patients with many chronic diseases were comparable to the percentages 
reported by Hernandez et al. (2013).  Also, the proportion of persons with an ejection 
fraction equal to or less than forty percent was similar to a previous report (Harjai et al., 
1999). Multiple diagnoses were related to 30-day unplanned rehospitalization, with 
chronic kidney disease and use of CPAP similar to previous reports by Aranda et al. 
(2009) and Kasai et al. (2008). Those findings could be explained by volume overload in 
patients with chronic kidney disease, and that will increase the workload of the heart 
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muscle, requiring frequent return to hospital to help patient lose these fluid through the 
diuresis process. The use of CPAP will help in supporting the patient’s airways, 
especially, at night. Patients with heart failure often sleep on several pillows to reach a 
comfortable position, which allows full expansion of the chest. The use of CPAP can 
reduce labored breathing and can help HF patients rest. In this study, chronic kidney 
disease and the use of CPAP were found to be significant predicators for 30-day HF 
unplanned rehospitalizations, which means HF rehospitalization could occur due to 
factors that are not cardiovascular related factors. At the same time, it was interesting to 
find that 30-day HF rehospitalization was not associated with any specific cardiovascular 
condition, which might be due to the fact that most of the patients experienced multiple 
comorbidities and cardiac conditions. 
The next set of findings were related to examination of the influence of 
physiological factors of laboratory values (normal and abnormal) on 30-day HF 
unplanned rehospitalization. The average of HbA1c was high in this sample and almost 
half of the patient records reviewed had both diabetes and HF. In addition, half of the 
medical records displayed that patients had a BNP of 630 or less, which showed an 
increase in ventricular secretion of this amino acid due to extra starching of the heart 
muscle, meaning that HF was worsening in this group. Only a few of the patients had 
troponin I levels of less than or equal 0.01, indicative that there was no minimal 
destruction to the heart muscle due to a lack of coronary blood supply. The average 
hemoglobin at admission and upon discharge was slightly less than the normal range and 
the hematocrit at admission and upon discharge were within the normal ranges. Findings 
 
82 
are similar to current literature that addressed the level of hemoglobin on admission as 
influencing 30-day HF rehospitalization (Felker et al., 2003; Prasun et al., 2013; Young 
et al., 2008). Consistent with the current study findings, Kosiborod et al. (2003) showed 
an increase in the risk of HF hospitalization with lower level hematocrit. Finally, 
hemoglobin level at discharge in the not rehospitalized group was similar to the study 
conducted by C Berry et al. (2005).  
There were no major electrolyte imbalances noted across the HF patients. The 
creatinine on admission and upon discharge in the rehospitalized group was significantly 
higher than the not rehospitalized group, similar to previous studies conducted by Prasun 
et al. (2013) and Bettencourt et al. (2007). Likewise, blood urea nitrogen on admission in 
the rehospitalized group was higher than the not rehospitalized group, consistent with the 
research outcomes from several studies (C Berry et al., 2005; Giamouzis et al., 2009; 
Sliwa et al., 2013). Finally, the BNP in the rehospitalized group was statistically 
significantly higher than the not rehospitalized group, another outcome similar to 
previous other reports (Bettencourt et al., 2007; Bettencourt et al., 2004; Pimenta et al., 
2007; Verdiani et al., 2008). 
The laboratory values were predictors of 30-day HF unplanned rehospitalization. 
Thus, close observations for blood levels such as cardiac enzymes, kidney function test, 
liver function test, and other blood works are vital to understanding the complete picture 
of 30-day HF unplanned rehospitalization. Achieving the preferred levels of multiple 
cardiac related laboratory markers can keep HF patients from 30-day unplanned 
rehospitalization. 
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Further analyses assessed the impact of cardiac related medications on 30-day HF 
unplanned rehospitalization. Medications used in the treatment of HF patients in this 
study were examined, with loop diuretics used more frequently than in a previous study 
by Hernandez et al. (2013). Findings from the current study were similar concerning the 
proportion of HF patients on beta-blockers and angiotensin converting enzymes inhibitors 
(Hernandez et al., 2013). The use of ACE inhibitors as vasodilator will reduce improve 
blood flow, and reduce the workload on the heart. Patients who used angiotensin 
converting enzymes were less likely to experience a 30 day HF unplanned 
hospitalization, similar to the study conducted by Corrao et al. (2015) and the study by G. 
C. Fonarow et al. (2007). In this study, only 46% of the participants were on ACE 
inhibitor, this was a low percentage, compared to the HF management guidelines, which 
states that use of ACE inhibitor is recommended to be used for all HF patients. It could 
be that health care providers are not educated on the importance of prescribing these 
medications, or patients are suffering kidney disease or having allergies to this type of 
medication. Therefore, comprehensive, and detailed assessment of discharge medications 
by the health care provider can enhance the possibility that the patient may experience 
reduced unplanned rehospitalizations. 
The third research question was used to examine the impact of psychological 
factors, mainly, depression and anxiety on 30-day HF unplanned rehospitalization. 
Depression and anxiety were found in one-fourth of the patients, which was less than the 
proportion found by Albert and Zeller (2009). Findings showed that the use of 
antidepressants was significantly associated with 30-day HF unplanned rehospitalization, 
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however, the use of antidepressants was not found to be a significant predictor for 30-day 
unplanned rehospitalization when included with other psychological factors. When 
included with combined factors from different modes, antidepressant was found to be a 
significant predictor in reducing 30- day unplanned rehospitalization. This could be 
explained because depression has been linked to worsening HF symptoms, and increased 
chances for rehospitalization (Song et al., 2009). The use of antidepressants can reduce 
the severity of depression, which decreases rehospitalization. In this study, the use of 
anxiolytics were noted in all patients with anxiety, which probably was why anxiety was 
not found to be significant in predicting 30-day unplanned rehospitalization. Findings 
displayed that the use of pharmacological management of depression can help in 
improving the health of HF patients and decrease unwanted outcomes, such as 30-day HF 
unplanned rehospitalization. 
The impact of role function factors on 30-day unplanned hospitalization was 
answered with question four. The research question was proposed to assess the impact of 
role function factors, mainly, marital status, living situation (alone or not), employment 
status and insurance status on 30-day HF unplanned rehospitalization. The study 
displayed that 22% were living alone, and when living alone the study found it to be a 
significant predictor for 30-day HF unplanned rehospitalization. Thirty day unplanned 
rehospitalization was lower for HF patients living alone compared to HF patients who 
lived with someone, similar  to a previous study that showed living with family increased 
the risk of HF rehospitalization (Hamner & Ellison, 2005). This result could be 
interpreted as if the patient lives alone, they tend to wait before they seek help. Often 
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persons living in the same house, such as family members or spouses, encourage persons 
to seek treatment for symptoms immediately. The results of this study was similar to the 
results from Roe-Prior (2007) study in that unmarried/single HF patients were  at higher 
risk for rehospitalization than married persons. The level of social support has shown 
influence on health outcomes, such as 30-day rehospitalization. The findings related to 
employment aligns with findings from another study that showed unemployment was 
significantly associated with an increased chances for 30-day HF unplanned 
rehospitalization (Tsuchihashi et al., 2001). For the final role function factor, findings 
showed that individuals with insurance were less likely than individuals without health 
insurance to experience 30-day unplanned rehospitalization.  
These results indicate that 30-day HF unplanned rehospitalization could be 
influenced by non-clinical variables, such as living status. Also, the role function factors 
should be added to the list of factors that are addressed when developing a plan of care 
and treatment in an attempt to reduce HF rehospitalization. 
The final research question was an examination of the combined impact of the 
multiple types of factors on 30-day HF unplanned rehospitalization. Findings showed 
significant relationships between the number of previous hospitalizations, differences in 
weight between discharge and admission, the use of angiotensin converting enzymes 
inhibitor, the use of antidepressants, not married and 30-day unplanned rehospitalization. 
Losing greater amounts of weight between admission and discharge, use of angiotensin 
converting enzymes and antidepressants, as well as being married were related to lower 
risk of rehospitalization, with consideration of the other factors. An increase in the 
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number of hospitalization was associated with a higher odds of 30-day HF unplanned 
rehospitalization.  
Conclusions 
State of science is that nursing is moving to more interventions, thus we need to 
understand more comprehensively why patients are rehospitalized. The findings showed 
that there are several factors and variables associated with 30-day HF unplanned 
rehospitalizations. The factors that were significantly associated and predicted 30-day HF 
unplanned rehospitalizations included, contextual factor patient characteristics, such as, 
the length of stay, New York heart failure classification (class II), body mass index, 
number of previous hospitalizations, and difference in weight between discharge and 
admission. For the physiological factors of cardiovascular and non-cardiovascular 
conditions, the diagnosis of chronic kidney disease, the use of CPAP were significantly 
associated with 30-day. Furthermore, physiological factors of laboratory values, such as, 
hemoglobin on admission and upon discharge, hematocrit at discharge, creatinine on 
admission and upon discharge, blood urea nitrogen on admission and upon discharge, B-
type Natriuretic peptide were found significantly associated with 30-day unplanned 
rehospitalization.  The final group of physiological factors showed the use of angiotensin 
converting enzymes inhibitor, and the use of antidepressants were among the variables 
that significantly predicted 30-day HF rehospitalization. Finally, role function factors of 
living situation, marital status, employment status, and insurance statues were found to 
predict HF rehospitalization. 
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The RAM was useful in developing the conceptual model for the study. The 
model was largely supported by the findings.  Factors in each of the three adaptive modes 
and the contextual stimuli influenced 30-day unplanned rehospitalization among this 
sample of HF patients using electronic medical records (Figure. 2).  The factors were 
similar to those found in previous studies. The physiological mode, which receives the 
most attention during hospitalization, was only one mode that contributed to 
understanding 30-day unplanned rehospitalization. Specific medication categories, 
diagnoses, living situations, social support and economics, as well as individual 
characteristics, influenced 30-day unplanned rehospitalization both individually and 
collectively.   
Families and communities influenced the occurrence of an unplanned 
hospitalization, especially among the HF patients.  Many of these factors for adaptation 
are within the control of the patient, while others are in the control of health 
professionals. Therefore, there is a critical need to develop an assessment tool, implement 
interventions and provide early identification of risk. 
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Figure 2. Summary for Factors that Influence 30-Day Unplanned Rehospitalization 
 
 
 
 
Implications 
 
Practice  
 
This study has assisted in identifying the factors and variables associated with 30-
day unplanned rehospitalization. These findings will help primary care providers, nurse, 
and hospital administration to develop the interventions and discharge plans to decrease 
the occurrence of 30-day unplanned rehospitalization among HF patients. Primary care 
 
89 
providers are encouraged to review, patient’s family history, and past medical history and 
laboratory values on a daily bases and address the abnormal values. In addition, health 
care providers need to reconcile patient’s medications at discharge, and make sure 
patients are discharged home on ACE inhibitors to reduce their chances for 30-day 
unplanned rehospitalizations, and antidepressants if they are diagnosed with depression. 
These recommendations are similar to those provided by the American Heart Association 
and the American College of Cardiology (Yancy et al., 2013). 
Nurses as case managers are in a key position to evaluate the factors associated 
with 30-day HF unplanned rehospitalization. Those factors include the living situation, 
insurance status, marital status, weight lost during hospitalization, number of previous 
hospitalizations, and the compliance with CPAP. This information will help in 
developing care plans that will reduce 30-day rehospitalization. Assessment by nurse case 
managers should include living situation and ensuring patients have social support in 
place to reduce chances for rehospitalization. Including families in community and 
hospital care and education can be used for this purpose.  Furthermore, working with 
uninsured patients and providing information that will help them sign up for insurance, or 
enroll them in programs designated to help HF patients with medication and follow up 
appointments with their primary care provider. Collaborations with social workers can 
provide this type of information and assistance. The use of CPAP reduces the work of 
breathing; consequently, decrease the chances for respiratory distress associated with HF.  
The reduction in the chances of respiratory distress will decrease the chance for 
rehospitalization. The education of HF patients regarding the use of medical equipment, 
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such as, CPAP is vital to increase patients’ compliance, and show HF patients how to use 
it properly.  
Education 
HF patients are in a unique position. They have a chronic condition, with several 
symptoms, and multiple medications prescribed. In addition, HF patients experience self-
management challenges to follow certain diets and specific physical activity 
recommendations. The role of the nurse or HF educator is to educate HF patients on all 
aspects, such as, medication adherence, activity and exercise, diet, monitoring fluid 
intake and weight, and to keep their follow up appointments with health care providers. 
Nurses and educators can work with HF patient to improve their adherence to treatment 
and encourage them to seek help when needed (Coby et al., 2009). This study has 
provided the areas that nurses and HF educators need to focus on in an effort to increase 
patient’s understanding, compliance, and consequently help in reducing HF 
rehospitalization. Nurses are in a key position to participate in reducing the rates of 30-
day unplanned rehospitalization. Their roles are essential in saving health care system 
from spending billions of dollars and increasing direct spending on health promotion and 
disease prevention, as well as alleviating family and community burden and improving 
quality of life for HF patients. 
The education of HF patients’ needs to address a variety of aspects. These areas 
can be addressed best by a qualified nurse, with a strong understanding of the predictors 
of HF. There are multiple programs available that aim to increase the understanding of 
this phenomenon, in addition, focus on educating HF patients on diet, activity level and 
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exercise, medication’s compliance, daily weight monitoring with keeping records, and 
the need to have family involvement in the process of caring for HF patients.  HF 
educators may utilize the results of this study and develop programs that emphasize the 
importance of compliance to prescribed medications, such as, ACE inhibitors, and 
antidepressants. Furthermore, building other programs that focus on importance of 
adherence to cardiac diet (low sodium level) monitoring weight and recording it daily. 
May provide additional achievement of positive outcomes for HF patients, including 
reduced likelihood of 30-day unplanned rehospitalization.   
Research 
The phenomenon has been addressed extensively in the current literature. 
Findings from this study align with the results of previous research studies. The current 
study has provided an extensive awareness in the understanding of 30-day HF unplanned 
rehospitalization. The results of this study indicated that different variables are associated 
or predict 30-day HF unplanned rehospitalization. Each factor identified in this study to 
be significantly associated with HF is an important area for future research. The results of 
this study such as, the length of stay, is important to focus on by other researchers. The 
length of stay was described in this study only as predictor, however, the causes for 
increase the length of stay could be evaluated separately, and recommendations to 
address the increase in the time spent at the hospital need to be evaluated further. 
Moreover, the net weight change during hospitalization was identified as a factor that 
influenced 30-day HF rehospitalizations. The exact amount of fluids HF patient’s need to 
lose before discharge is an area that can be studied further with a different populations or 
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different sample size. In addition, preventive efforts and their effect on maintaining fluid 
balance among HF patients should be evaluated through formal study. The BMI was 
found to be associated to an increased chance for 30-day HF unplanned rehospitalization; 
therefore, body mass index could be evaluated by focusing on those with higher BMI, 
which might be related to increase in weight.  Number of previous hospitalization was 
identified as a factor associated with HF rehospitalization. The number of and time frame 
for hospitalizations is an area for research.  As mentioned in chapters 1 and 2, differing 
time periods for HF readmission have been used in previous research. The initiation of 
the CMS rule regarding 30-day readmission should take precedence in future research. 
The living situation, and the level of family support, and the type of insurance could be 
investigated more in research.  Future research will require larger sample sizes to conduct 
studies with additional factors within the adaptive modes.  Moreover, researchers are 
encouraged to use other complex analyses, such as, cluster analysis to validate the 
findings of the current study, and provide additional understanding of 30-day HF 
unplanned rehospitalizations.  
Limitations 
A number of limitations exist in the study that limits the generalizability of the 
findings. A larger sample is needed to validate the findings further. The type and 
definition of data variables were constrained by the available EMR data.  Additional 
definitions and availability of data points, such as, the number of participants that were 
not working due to disability or retirement may provide further understanding of 30-day 
HF unplanned rehospitalization. Data were obtained from a local hospital in a small 
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urban area, thus the results may not be reflective of all HF patient outcomes.  In addition, 
there were some challenges because not all data points were available for all patient 
records.  
Summary 
Thirty-day HF rehospitalization has been an area of interest for researchers in this 
field for the past few decades. Thirty-day HF unplanned rehospitalization has been, and 
continues to be the focus of health care providers, nurses, researchers and payers. The 
interest in decreasing the rates of HF 30-day unplanned rehospitalization remains a 
priority for government, health care systems, payers, families and communities. The 
results of previous reports and interventions targeting this phenomenon have not been 
consistent in producing the outcomes desired. Identifying different factors that influence 
30-day unplanned rehospitalization in HF was the focus of this study to provide a basis 
for developing tailored interventions and a successful discharge plan that focused on 
specific patients’ needs. This study aimed to identify the factors that influence 30-day HF 
unplanned rehospitalization. 
This study was guided by Roy adaption model using variables that represented the 
contextual stimuli and three adaptive modes. Two hundred and seventy electronic 
medical records were reviewed and used based on the inclusion and exclusion criteria. 
Several factors including patient’s characteristics, physiological factors, psychological 
factors, and role function factors were associated with 30-day HF unplanned 
rehospitalization. This study was similar to previous reports in most cases. Thus, the 
conceptual model was useful in providing a better understanding of 30-day 
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rehospitalization among this sample of HF patients. Findings provide a basis on which to 
plan care while in the hospital, upon discharge and while at home.  Providers, 
professionals, families and communities can use the findings to strengthen self-care, 
monitoring of diet, medications and weight, plan for post hospital follow up and regular 
follow up due to the nature of HF.  Future research needed in the several areas. 
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APPENDIX A 
 
THE HEART FAILURE DATA COLLECTION TOOL 
 
 
Patient’s code (code)  
Rehospitalized/Not rehospitalized 1. Rehospitalized  
2. Not rehospitalized  
Age (age)  ______ Years  
  
Gender (gender) 1)Male        2) Female  
Race (race) 1. White 
2. Black 
3. Hispanic 
4. Asian 
5. Native American  
6. Others__________ 
Length of stay (LOS) ______day (s) first 
admission 
Zip code (Zip) (Rural/Urban) ______ 
Marital status (Marit_stat) 1. Single 
2. Married 
3. Divorced  
4. Widowed 
BMI(BMI)  _______  
Number of Previous HF hospitalization (Pre_hosp) _________# past three 
years 
Lives alone (alone) 1)Yes               2) NO 
Difference between weight on discharge and weight on 
admission (wt_diff) (calculated) 
  
_______ kg 
The diagnosis of Diabetes (DM) 1)Yes               2) NO 
The diagnosis of Hypertension(HTN) 1)Yes               2) NO 
The diagnosis of Atrial fibrillation(A_Fib) 1)Yes               2) NO 
The diagnosis of Coronary artery disease (CAD) 1)Yes               2) NO 
The diagnosis of Myocardial infarction (MI) 1)Yes               2) NO 
The diagnosis of Angina pectoris (angina) 1)Yes               2) NO 
The diagnosis of Stroke (stroke) 1)Yes               2) NO 
The diagnosis of Anemia (anemia) 1)Yes               2) NO 
The diagnosis of Hyponatremia (hyponat) 1)Yes               2) NO 
The diagnosis of Hypokalemia (hypoKal) 1)Yes               2) NO 
The diagnosis of Chronic kidney disease (kidney_dis), 1)Yes               2) NO 
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The diagnosis of Chronic obstructive pulmonary disease 
(COPD) 
1)Yes               2) NO 
The diagnosis of Obstructive Sleep Apnea  (OSA) 1)Yes               2) NO 
The diagnosis of Depression (depression) 1)Yes               2) NO 
The diagnosis of Anxiety (anxiety) 1)Yes               2) NO 
The use of CPAP (CPAP) 1)Yes               2) NO 
New York Heart Association for HF classification 
(HF_class) 
1. Class I 
2. Class II 
3. Class III 
4. Class IV 
Ejection fraction (EF) _________ 
 
The level of Hemoglobin on admission (Hb_ad)  _______ g/dl 
The level of Hemoglobin at discharge (Hb_dc) _______ g/dl 
The level of Hematocrit on admission (Hct_ad)  _______ % 
The level of Hematocrit at discharge (Hct_dc)  _______ % 
The level of sodium on admission (Na_ad)  _______ mEq/L 
The level of sodium at discharge (Na_dc)  _______ mEq/L 
The level of potassium on admission (K_ad)  _______ mEq/L  
The level of potassium at discharge (K_dc)  _______ mEq/L  
The level of hemoglobin A1c (HbA1c)  ________ % 
The level of creatinine on admission (Cr_ad)  _______mg/dl 
The level of creatinine at discharge (Cr_dc)  _______mg/dl 
The level of total bilirubin on admission (bil_ad)  _______mg/dl 
The level of total bilirubin at discharge (bil_dc)  _______mg/dl 
The level of blood urea nitrogen on admission (BUN_ad)  _______mg/dl 
The level of blood urea nitrogen at discharge (BUN_dc)  _______mg/dl 
The level of uric acid on admission (uric_acid_ad)  _______mg/dl 
The level of uric acid at discharge (uric_acid_dc)  _______mg/dl 
The level of B-type natriuretic peptide (BNP)  _______pg/mL 
The level of C-reactive protein (CRP)  _______mg/l 
The level of cardiac Troponin I  (Troponin_I) Troponin I:______ µg/L   
The level of cardiac Troponin T (Troponin_T) Troponin T:______ µg/L 
The use of loop diuretics (loop_diur) 2) No    1) Yes: 
________________ 
The use of Thiazides (HCTZ) 2) No    1) Yes: 
________________ 
The use of potassium-sparing diuretics (spironolactone)  2) No    1) Yes: 
________________ 
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The use of Beta-Blocker (BB) 2) No    1) Yes: 
________________ 
The use of Angiotensin Converting Enzymes inhibitor 
(ACE) 
2) No    1) Yes: 
________________ 
The use of Angiotensin II Receptor Blockers (ARB) 2) No    1) Yes: 
________________ 
The use of antidepressants  2) No    1) Yes: 
________________ 
The use of anxiolytics 2) No    1) Yes: 
________________ 
Insurance status (insured) 2) No    1) Yes:  
Insurer 
:________________ 
Employment status (employ) 2)No    1)Yes___________ 
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APPENDIX B  
 
LIST OF VARIABLES 
 
 
Variable (code) Measurement  ICD-9 
code  
Contextual factors 
Age (age) Continues  N/A 
Gender (gender) Categorical N/A 
Race (race) Categorical  N/A 
Length of stay (LOS) Continues  N/A 
Zip code (Zip) (Rural/Urban) N/A N/A 
Previous HF hospitalization (Pre_hosp) Categorical N/A 
New York Heart Association for HF classification 
(HF_class) 
Categorical  N/A 
Physiologic-physical factors 
The diagnosis of Diabetes (DM) Categorical 249.00 
The diagnosis of Hypertension(HTN) Categorical 401.9 
The diagnosis of Atrial fibrillation(AF) Categorical 427.31 
The diagnosis of Myocardial infarction (MI) Categorical 410.00 
The diagnosis of Angina pectoris (angina) Categorical 413.9 
The diagnosis of Stroke (stroke) Categorical V17.1 
The diagnosis of Anemia (anemia) Categorical 280.0 
The diagnosis of Hyponatremia (hyponat) Categorical 276.1 
The diagnosis of Chronic kidney disease (kidney_dis) Categorical 585.1 
The diagnosis of Chronic obstructive pulmonary disease 
(COPD) 
Categorical 490-492, 
494, 496 
Ejection fraction (EF) Continues N/A 
The use of CPAP (CPAP) Categorical N/A 
The diagnosis of Obstructive Sleep Apnea (OSA) Categorical 327.23 
The level of hemoglobin on admission (Hb_ad) Continues N/A 
The level of hemoglobin at discharge (Hb_dc) Continues N/A 
The level of hematocrit on admission (Hct_ad) Continues N/A 
The level of hematocrit at discharge (Hct_dc) Continues N/A 
The level of sodium on admission (level_Na_ad) Continues N/A 
The level of sodium at discharge (level_Na_dc) Continues N/A 
The level of potassium on admission (level_K) Continues N/A 
The level of potassium at discharge (K_dc) Continues N/A 
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The level of hemoglobin A1c (HbA1c) Continues N/A 
The level of creatinine on admission (Cr_ad) Continues N/A 
The level of creatinine at discharge (Cr_dc) Continues N/A 
The level of total bilirubin on admission (bil_ad) Continues N/A 
The level of total bilirubin at discharge (bil_dc) Continues N/A 
The level of blood urea nitrogen on admission (BUN_ad) Continues N/A 
The level of blood urea nitrogen at discharge (BUN_dc) Continues N/A 
The level of uric acid on admission (uric_acid_ad) Continues N/A 
The level of uric acid at discharge (uric_acid_dc) Continues N/A 
The level of B-type natriuretic peptide (BNP) Continues N/A 
The level of cardiac troponin (troponin) Continues N/A 
The use of Loop diuretics (loop_diur), Categorical N/A 
The use of Thiazides (HCTZ) Categorical N/A 
The use of Potassium-sparing diuretics (spironolactone)   Categorical N/A 
The use of Beta-Blocker (BB) Categorical N/A 
The use of Angiotensin Converting Enzymes inhibitor 
(ACE_inhibitor) 
Categorical N/A 
The use of Angiotensin II Receptor Blockers (ARB) Categorical N/A 
Self-concept mode factors 
The diagnosis of Depression (depression) Categorical V79.0 
The diagnosis of Anxiety  Categorical 300.02 
The use of Antidepressants Categorical N/A 
The use of Anxiolytics  Categorical N/A 
Role function mode factors 
Insurance status (insured) Categorical N/A 
Employment status (employ) Categorical N/A 
Living situation  (Alone) Categorical  N/A 
Marital status (married) Categorical  N/A 
 
